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1
CHAPTER 1

INTRODUCTION

Parts of this chapter have been submitted for publication in the journal of
Advances in Experimental Medicine and Biology, Springer (invited review).

1.

Role of CL in cellular signaling – an overview
It is not unusual to find even current depictions of membranes as

homogenous lipid matrices that function primarily to support the allegedly
important protein molecules embedded within. This belies the fascinating
discoveries in the past two decades of cellular and organelle-specific functions
attributed to individual membrane lipids, and of the plethora of regulatory and
signaling molecules derived from glycerolipids and sphingolipids. In this light, it
is essential to elucidate the functions of specific membrane lipids and the cellular
consequences of their depletion.
A phospholipid that has been the focus of considerable attention relatively
recently - although it was first isolated and purified from beef heart in 1942
(Pangborn, 1942; Pangborn, 1947), is cardiolipin (CL). CL is structurally unique.
In contrast to the other membrane phospholipids, in which a single glycerol
backbone is acylated to two fatty acid chains, CL contains two phosphatidyl
groups (linked to a glycerol backbone) and four fatty acyl chains. It is enriched in
energy harvesting membranes of mitochondria, chloroplasts, bacterial plasma
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membranes, and hydrogenosomes, underscoring the importance of this lipid in
energy production (Corcelli, 2009; Depalo et al., 2004; Dowhan, 1997). CL is
tightly associated with mitochondrial proteins and respiratory chain complexes
and is essential for their optimal activity (Fry et al., 1980; Fry and Green, 1980;
Fry and Green, 1981; Lange et al., 2001a; Pfeiffer et al., 2003). In the inner
membrane, CL provides structural stability to membrane proteins through
hydrophobic and electrostatic interactions.
In light of its association with the respiratory apparatus, the role of CL in
mitochondrial bioenergetics was not entirely unexpected. Interestingly, however,
recent studies carried out primarily in yeast indicate that CL is also required for
cellular functions that are not directly associated with oxidative phosphorylation.
In accordance with a broad definition of a ‘bioactive lipid’ as one in which
changes in levels lead to functional consequences (Hannun and Obeid, 2008),
perturbation of CL composition (including CL levels, acyl species, and degree of
peroxidation) leads to dramatic cellular consequences: (1) Alterations in CL
levels and acyl chain composition increases the recruitment to the mitochondria
of cytosolic proteins that trigger apoptosis (Kagan et al., 2005; Kuwana et al.,
2002; Schug and Gottlieb, 2009). (2) Perturbation of CL synthesis or remodeling
leads to increased production of reactive oxygen species (ROS), which induces
aging (Cao et al., 2009; Chen et al., 2008a; Lee et al., 2006; Li et al., 2012; Li et
al., 2010; Paradies et al., 2010). (3) Blocking CL synthesis in yeast at the first
step of the pathway deleteriously affects cell wall biogenesis and alters the
response of two signaling pathways, the protein kinase C (PKC)-Slt2 mitogen
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activated protein kinase (MAPK) and the high osmolarity glycerol (HOG)
pathways (Zhong et al., 2005; Zhong et al., 2007; Zhou et al., 2009). (4) The
inability of yeast cells to synthesize CL leads to decreased vacuolar function and
reduced V-ATPase activity, suggesting that CL mediates cross talk between
mitochondria and the vacuole (Chen et al., 2008b).

2.

CL biosynthesis and remodeling
One of the most intriguing aspects of CL biosynthesis is that the lipid that

is initially synthesized contains primarily saturated fatty acids, while the mature
CL that is essential for normal cellular function contains primarily unsaturated
fatty acids. The distinct composition of acyl chains is achieved through a highly
conserved pathway of synthesis and remodeling, as shown in Fig. 1.1. The first
step is catalyzed by phosphatidylglycerolphosphate (PGP) synthase (Pgs1),
which converts CDP-diacylglycerol (DAG) and glycerol-3-phosphate (G-3-P) to
PGP (Chang et al., 1998a; Kawasaki et al., 1999). PGP is dephosphorylated to
phosphatidylglycerol (PG) by PGP phosphatase (Gep4) (Osman et al., 2010;
Zhang et al., 2011). The mammalian homologue of the yeast GEP4 gene was
recently identified as protein tyrosine phosphatase localized in the mitochondrion
1 (Zhang et al., 2011). CL synthase (Crd1) catalyzes an irreversible
condensation reaction in which the phosphatidyl group of CDP-DAG is linked to
PG via cleavage of a high-energy anhydride bond to form CL (Chang et al.,
1998b; Chen et al., 2006; Hostetler et al., 1971; Hostetler et al., 1972;
Houtkooper et al., 2006; Jiang et al., 1997; Tamai and Greenberg, 1990; Tuller et
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al., 1998). CL synthase does not show strong preference for specific fatty acyl
chains (Hostetler et al., 1975; Houtkooper et al., 2006; Nowicki et al., 2005).
How, then, is acyl specificity achieved? The newly synthesized CL undergoes
deacylation by a CL-specific deacylase (Cld1), which is homologous to the
mammalian phospholipase A2 (Beranek et al., 2009; Mancuso et al., 2009;
Mancuso et al., 2007). Cld1 removes one saturated fatty acyl chain from CL to
form monolysocardiolipin (MLCL) (Beranek et al., 2009). The transacylase
tafazzin (Taz1) reacylates MLCL with an unsaturated fatty acid to form mature
CL (Gu et al., 2004; Xu et al., 2003b; Xu et al., 2006). Taz1 carries out a
bidirectional exchange of acyl chains between CL and phosphatidylcholine (PC)
to sequentially replace the fatty acyl chains from all four acyl positions of CL
(Malhotra et al., 2009). The end result of this exchange is molecular symmetry of
CL molecules across the eukaryotic kingdom, from yeast to humans, which is
characteristic of the organism and of specific tissues and organs (Schlame et al.,
2005). For example, in yeast, the mature form of CL contains oleic acid, while CL
in the normal human heart is primarily tetralinoleoyl-CL (L4-CL) (Schlame et al.,
2005). A deficiency of tafazzin in humans leads to a complete absence of L4-CL,
resulting in the severe cardiomyopathy observed in BTHS.
While tafazzin is the only known yeast enzyme that adds fatty acyl chains
to MLCL, two other enzymes in addition to tafazzin remodel CL in mammalian
cells. MLCL acyltransferase-1 (MLCLAT1), isolated and purified from pig liver
mitochondria, shows specificity for linoleate (Taylor and Hatch, 2003). Thus,
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Figure 1.1 Synthesis and remodeling of CL in yeast. CL synthesis begins with
the

conversion

of

CDP-diacylglycerol

(CDP-DG)

to

phosphatidylglycerolphosphate (PGP) by PGP synthase (encoded by PGS1).
PGP is dephosphorylated to phosphatidylgylcerol (PG) by GEP4-encoded PGP
phosphatase. CL synthase (Crd1 define in the text for either lower or capital
case) converts PG to premature CL containing primarily saturated fatty acids
(FA). CL is deacylated by CL deacylase (Cld1) to monolyso-CL (MLCL), which is
reacylated by the TAZ1-encoded enzyme tafazzin to mature CL containing
primarily unsaturated fatty acids. The yeast gene names are depicted in green,
while phospholipids and their intermediates are shown in red.
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over-expression of MLCLAT1 in tafazzin-deficient BTHS lymphoblasts increased
incorporation of linoleic acid into CL, and RNAi knockdown of MLCLAT1 in HeLa
cells showed reduced linoleic acid inclusion in CL (Taylor and Hatch, 2009). The
biological function of this enzyme is not clear.

A second enzyme, acyl-

CoA:lysoCL acyltransferase 1 (ALCAT1), identified in mouse, was initially
thought to be located in the endoplasmic reticulum, but was subsequently
determined to be present in the mitochondrial-associated membranes, where
phospholipid traffic between the endoplasmic reticulum and the mitochondria
takes place (Cao et al., 2004; Li et al., 2010). In contrast to MLCLAT1, ALCAT1
shows no specificity for linoleic acid. ALCAT1 was shown to catalyze CL
remodeling to incorporate long chain polyunsaturated fatty acyl chains such as
docosahexaenoic acid (DHA) (Li et al., 2010). Enhanced incorporation of
polyunsaturated fatty acyl chains in CL makes it more susceptible to oxidative
damage by ROS, causing early peroxidation (Hong et al., 2002; Ng et al., 2005;
Watkins et al., 1998). ALCAT1 null mutant mice exhibit elevated CL levels along
with increased L4-CL (Li et al., 2012; Li et al., 2010), whereas overexpression of
ALCAT1 has been shown to decrease total CL levels and increase incorporation
of long chain polyunsaturated fatty acyl chains (Sparagna and Lesnefsky, 2009).
These findings suggest that ALCAT1 may negatively regulate CL biosynthesis.
In light of the importance of CL in cellular function, it is not surprising that
perturbation of CL synthesis leads to serious illness. The most direct example of
this link is seen in BTHS, a life-threatening illness characterized by dilated
cardiomyopathy and sudden death from arrhythmia (Barth et al., 1999a;
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Christodoulou et al., 1994). BTHS results from mutation in the CL remodeling
enzyme tafazzin (Bione et al., 1996a; Xu et al., 2003a). This leads to an
abnormal CL profile characterized by decreased total CL, increased monolysoCL, and aberrant CL acylation, most notably the loss of the predominant CL
species in normal myocardium, L4-CL (Vreken et al., 2000). How these
abnormalities cause the associated pathology in BTHS is not known (Schlame et
al., 2002).
CL abnormalities have also been observed in heart failure (Saini-Chohan
et al., 2009; Sparagna et al., 2007). Heart failure due to dilated cardiomyopathy
is the primary cause of death in diabetic patients (Garcia et al., 1974; Nichols et
al., 2001). Metabolic perturbations observed in diabetic cardiomyopathy include
increased utilization of fatty acid substrates, decreased utilization of glucose, and
mitochondrial dysfunction (Fang et al., 2004; Poornima et al., 2006; Wang et al.,
2006). However, the molecular mechanism that leads to heart failure in diabetic
patients is not known. Interestingly, a decrease in CL levels and alterations in CL
acyl species were found in early stages of diabetes induced by streptozotocin in
mice, suggesting that mitochondrial dysfunction and cardiomyopathy may be due
to alterations in CL metabolism (Han et al., 2005; Han et al., 2007). The
decrease in CL levels may result from remodeling of CL fatty acyl species with
DHA, which is known to cause CL peroxidation by ROS (Hong et al., 2002; Ng et
al., 2005; Watkins et al., 1998). In summary, depletion of CL content and
alterations in CL fatty acyl species lead to BTHS, and may also contribute to
pathological conditions and metabolic perturbations in other human disorders.
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3.

CL and apoptosis
Perturbations in CL levels and acyl composition play a crucial role in

regulating apoptosis, the complex process leading to programmed cell death.
The role of CL in apoptosis derives from its interactions with cytochrome c (Cyt c)
and with apoptotic proteins (Fig. 1.2).
i) CL and Cyt c. Interactions between CL and Cyt c are an important
determinant of apoptosis. Cyt c, which transfers electrons from complex III to
complex IV, is bound to the outer leaflet of the mitochondrion inner membrane
through interactions with CL (Gorbenko, 1999; Iverson and Orrenius, 2004). The
binding of Cyt c to CL is essential to anchor it to the inner membrane, and
release of Cyt c to the cytosol serves as a signal to recruit apoptotic proteins to
the mitochondria to initiate apoptosis (Choi et al., 2007; Petrosillo et al., 2006;
Spooner and Watts, 1992; Tuominen et al., 2002). CL binds Cyt c in two different
conformations - a loosely bound state that is facilitated by means of electrostatic
interactions, and a tightly bound state that is mediated by hydrophobic
interactions in which Cyt c is partially embedded in the inner membrane
(Gorbenko, 1999; Iverson and Orrenius, 2004). Release of Cyt c from CL
requires dissociation of both electrostatic and hydrophobic interactions (Ott et al.,
2002). The production of ROS may alter the CL-Cyt c association (Ott et al.,
2002; Petrosillo et al., 2006; Petrosillo et al., 2003). Alternatively, the
peroxidation of CL by hydrogen peroxide generated in the mitochondria leads to
the release of Cyt c from the tightly bound state into the intermembrane space
(Belikova et al., 2006; Kagan et al., 2005).
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Figure 1.2. Perturbation of CL metabolism triggers apoptosis. The binding of
cytochrome c (Cyt c) to CL is essential to anchor it to the inner mitochondrial
membrane, facing the intermembrane space. Peroxidation of CL (CL-OOH) by
reactive oxygen species (ROS) leads to release of Cyt c to the cytosol, which
serves as a signal to initiate apoptosis. Caspase-8 cleaves Bid protein to its
active form, truncated Bid (t-Bid). Binding of t-Bid to CL enhances translocation
of CL to the outer mitochondrial membrane, which facilitates targeting of
apoptotic proteins (Bak and Bax) to the outer membrane.
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ii) Recruitment of apoptotic proteins. An early trigger of apoptosis is the
change in CL composition in the mitochondrial inner and outer membranes,
followed

by

dissipation

of

the

membrane

potential

and

flipping

of

phosphatidyserine (PS) to the external surface of the plasma membrane (Garcia
Fernandez et al., 2002; Thiagarajan and Tait, 1990). A diverse set of apoptotic
proteins such as t-Bid, Bax, Bak, and caspase-8 are recruited to the
mitochondrial surface of cells undergoing apoptosis in a CL-dependent manner
(Gonzalvez et al., 2010; Gonzalvez et al., 2008; Li et al., 1998). Upon activation,
caspase-8 migrates to the mitochondrial outer membrane in regions where CL is
present. Caspase-8 is said to cleave Bid to its active form, tBid (truncated Bid). A
significant amount of CL is translocated from the inner to the outer mitochondrial
membrane, which likely serves as a signal for binding of the apoptotic proteins
(Gonzalvez et al., 2005; Kuwana et al., 2002; Lutter et al., 2000). The binding of
t-Bid to CL is thought to further increase CL transfer to the outer membranes.
Alternatively, apoptotic proteins may be guided to the mitochondria by means of
altering the outer membrane charge (Heit et al., 2011). By increasing the CL
content, the mitochondrial outer membrane may accrue a more negative charge,
which serves as a targeting signal for recruiting polycationic apoptotic proteins to
the mitochondria (Aguilar et al., 1999; Lutter et al., 2000). Consistent with this,
ectopic overexpression of a CL-binding protein masked the negative charge on
the membrane and inhibited apoptosis (Heit et al., 2011). The recruitment to and
oligomerization of Bak-Bax in the outer mitochondrial membrane is a CL
dependent process, which permeabilizes the outer mitochondria to trigger Cyt c
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release and progression of apoptosis (Liu et al., 2004; Sani et al., 2009). This
suggests that CL-rich regions in the outer membrane serve as a key signal for
targeting pro-apoptotic proteins of the Bcl2 family to bring about apoptosis (Lutter
et al., 2000; Lutter et al., 2001).
iii) Translocation of CL. Early in apoptosis, CL translocation from the
inner to the outer mitochondrial membrane may be carried out through several
transport modes. First, CL is enriched at the inner and outer membrane contact
sites, which are enriched in CL through interactions with mitochondrial creatine
kinase (MtCK), could facilitate the transfer of CL from the inner to outer
membrane (Epand et al., 2007a; Epand et al., 2007b; Maniti et al., 2009;
Schlame and Augustin, 1985; Schlattner et al., 2004; Speer et al., 2005).
Second, phospholipid scramblase-3 (PLS-3) has been shown to translocate CL
from the inner membrane to the outer membrane during the onset of apoptosis
(Liu et al., 2003a; Liu et al., 2003b; Van et al., 2007). Consistent with this, cells
overexpressing PLS-3 exhibit increased apoptosis, while inactivation of PLS-3
leads to increased resistance to UV-induced apoptosis (Liu et al., 2003b). CL and
Bid interactions have been shown at the contact sites, which likely contribute to
mitochondrial permeabilization to induce apoptosis (Kim et al., 2004). Changes in
CL content in the membrane may be mediated by Bid, as evidence suggests that
Bid exhibits lipid transfer activity (Esposti et al., 2001; Sorice et al., 2004).
Lymphoblastoid cells derived from BTHS and TAZ knockdown HeLa cells were
more resistant to Fas-induced apoptosis (Gonzalvez et al., 2008). Specifically,
reduction of mature CL caused defective activation of caspase-8, suggesting that
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processing of caspase-8 on the mitochondrial membranes is CL-dependent. To
summarize, CL in the mitochondria is an important mediator of apoptosis, and
apoptotic proteins are directed to the mitochondria in a CL-dependent manner.

4.

CL in bioenergetics and mitochondrial dysfunction
The relationship between CL and ROS is complex. The important role of

CL in mitochondrial bioenergetics suggests that CL deficiency may lead to an
increase in ROS, which is generated in the mitochondria as a byproduct of
oxidative phosphorylation (Barros et al., 2003; Grant et al., 1997; Pitkanen and
Robinson, 1996). CL physically interacts with proteins of the mitochondrial
respiratory chain complexes and other components of the membrane and forms
lipid scaffolds for tethering and stabilizing mitochondrial membrane proteins to
enhance their enzymatic activities (Beyer and Klingenberg, 1985; Beyer and
Nuscher, 1996; Fry and Green, 1980; Fry and Green, 1981; Joshi et al., 2009;
Sedlak and Robinson, 1999). Consistent with this role in bioenergetics,
mitochondria deficient in CL exhibit decreased activity of respiratory complexes
and carrier proteins (Claypool, 2009), and CL deficiency leads to an increase in
ROS (Chen et al., 2008a). ROS, in turn, damages CL by peroxidation of the
unsaturated fatty acids.

i) CL and supercomplexes
For efficient substrate channeling between the individual complexes, the
mitochondrial respiratory chain components are organized in supramolecular
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structures called supercomplexes (Schagger and Pfeiffer, 2000). In mammalian
cells, complex I is associated with two units of complex III and multiple units of
complex IV. In S. cerevisiae, which lacks complex I, two copies of complex III are
bound to either one or two units of complex IV. CL deficiency in yeast leads to
destabilization of the respiratory supercomplexes, indicating that CL functions to
stabilize these complexes (Pfeiffer et al., 2003; Zhang et al., 2002a; Zhang et al.,
2005a). Similarly, tafazzin deficient human fibroblasts exhibit destabilization of
the supercomplexes (McKenzie et al., 2006). For efficient ADP/ATP exchange,
CL is also required for the association of the ADP/ATP carrier protein with the
supercomplexes (Claypool et al., 2008).

ii) CL deficiency and ROS generation. The role of CL in the
supercomplexes may be that of a proton trap, to avoid leakage of protons and
enhance the membrane potential for efficient oxidative phosphorylation (Haines
and Dencher, 2002; Hoch, 1998; Jiang et al., 2000). CL may also reduce leakage
of electrons, which can increase the generation of ROS. Not surprisingly,
defective supercomplex formation and CL deficiency lead to increased ROS
production (Chen et al., 2008a; Chen et al., 2012).
Among the respiratory chain complexes, complexes I and III are prime
sites for ROS generation (Barja, 1999; Grivennikova and Vinogradov, 2006;
Kushnareva et al., 2002; Turrens et al., 1985). Because of the proximity of CL to
these ROS generating centers, the unsaturated fatty acyl chains of CL are
susceptible to damage by peroxidation. Superoxide generated by respiratory
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complex III causes peroxidation of CL and alters the activity of Cyt c oxidase
(Paradies et al., 2000; Paradies et al., 2001; Paradies et al., 1998). Optimal
function of Cyt c oxidase, the terminal enzyme complex of the respiratory chain,
is dependent on CL (Abramovitch et al., 1990; Fry et al., 1980; Powell et al.,
1987; Robinson et al., 1980). Reduced activity of Cyt c oxidase from reperfused
heart was restored specifically by exogenous supplementation of CL, but not by
peroxidized CL or other phospholipids (Paradies et al., 1999b). In addition,
reduced activity and increased ROS generation by complexes I and III were also
rescued by CL supplementation (Paradies et al., 2001; Petrosillo et al., 2007).
These studies indicate that peroxidized CL cannot effectively carry out
mitochondrial functions that are dependent on normal CL.
Peroxidation of CL by ROS is seen as the primary cause of CL
mobilization to the outer leaflet of the inner membrane. Human leukemia cells
treated with the apoptosis-inducing drug staurosporine rapidly underwent
apoptosis along with an increase in CL content in the outer mitochondrial
membrane (Garcia Fernandez et al., 2002). However, the change in CL content
was preceded by increased ROS production and CL peroxidation, suggesting
that perturbation of CL metabolism could be an early step in mitochondriainduced apoptosis. Due to the high content of unsaturated fatty acyl chains, CL is
particularly susceptible to peroxidation (Ferlini et al., 1999; Ushmorov et al.,
1999). Peroxidation of CL alters the molecular conformation leading to formation
of non-bilayer hexagonal structures, which could serve as a marker for targeting
the cytosolic apoptotic machinery to the mitochondria (Aguilar et al., 1999).
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iii) CL in mitochondrial dysfunction and aging. Under normal
physiological conditions, the damaged fatty acyl chains of CL may be replaced
through the remodeling process (Malhotra et al., 2009). Pathological remodeling
of CL has been linked to mitochondrial dysfunction in human diseases (Han et
al., 2007; Lee et al., 2006; Li et al., 2010; Saini-Chohan et al., 2009). As
discussed above, loss of the CL remodeling enzyme tafazzin leads to BTHS.
Recent studies have shown that ALCAT1 may be involved in the pathological
remodeling of CL in cells undergoing oxidative stress. As mentioned earlier,
ALCAT1 overexpression leads to a decrease in CL levels and aberrant
remodeling of CL with long chain polyunsaturated acyl chains such as DHA,
which are highly susceptible to oxidation by ROS (Hong et al., 2002; Li et al.,
2010; Watkins et al., 1998). The close proximity of CL to respiratory complexes in
the inner membrane where ROS is generated increases exposure of these long
chain unsaturated fatty acyl chains to ROS. Aberrant CL remodeling resulting
from increased ALCAT1 expression leads to the mitochondrial dysfunction seen
in pathological conditions such as hyperthyroid cardiomyopathy, diabetes, and
diet-induced obesity in mice (Cao et al., 2009; Li et al., 2012; Li et al., 2010; Liu
et al., 2012). ALCAT1 null mice exhibit increased expression of MLCAT1 along
with elevated levels of CL containing linoleic acid. These findings underscore the
significance of CL remodeling and the impact of this process on mitochondrial
function and ROS generation.
A decline in CL levels appears to be a primary feature of aging (Lenaz et
al., 1997; Lewin and Timiras, 1984; Maftah et al., 1994; Paradies and Ruggiero,
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1990; Paradies et al., 1993; Paradies et al., 1997). In aging cells, CL is
pathologically remodeled with polyunsaturated fatty acyl chains such as
arachidonic and docosahexaenoic acids, which are more susceptible to
peroxidation than linoleic acid in normal CL (Lee et al., 2006; Sparagna and
Lesnefsky, 2009). Mitochondrial CL levels, along with oxidative capacity and
ATP synthesis, decrease significantly with age (Hagen et al., 1998a; Hoch, 1992;
Maftah et al., 1994; Sen et al., 2007; Sen et al., 2006).
CL is required for the optimal function of several mitochondrial carrier
proteins involved in the transport of essential metabolites into mitochondria
(Claypool, 2009). In the heart, oxidation of pyruvate and β-oxidation of fatty acids
are two major sources of ATP generation (Christe and Rodgers, 1994; DavilaRoman et al., 2002; Wisneski et al., 1985). The transport of pyruvate into
mitochondria by the pyruvate carrier and the exchange of carnitine esters by the
carnitine:acylcarnitine translocase are, therefore, critical for energy metabolism.
Studies have demonstrated that enzymatic activities of both the mitochondrial
pyruvate carrier and carnitine:acylcarnitine translocase, which are dependent on
CL (Nalecz et al., 1986; Noel and Pande, 1986), are decreased in aging heart
muscle (Paradies et al., 1999a; Paradies et al., 1995). Interestingly,
administration of acetyl-L-carnitine in aged rats restored decreased CL levels and
the activities of the mitochondrial pyruvate carrier and carnitine:acylcarnitine
translocase to levels found in young rats (Paradies et al., 1999a; Paradies et al.,
1995). Dietary supplementation of acetyl-L-carnitine also showed similar
beneficial effects, increasing mitochondria membrane potential and, in turn,
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improving physical mobility in aged rats (Hagen et al., 1998a; Hagen et al.,
1998b). These findings suggest that the supply of carnitine to the mitochondria
may become limited during aging, hindering energy production through βoxidation (Maccari et al., 1990; Paradies et al., 1995). Although acetyl-L-carnitine
supplementation restored CL levels and improved mitochondrial metabolic
functions in aged animals, the underlying molecular mechanism remains
unresolved.

5.

CL and the PKC-Slt2 cell integrity pathway:
Null mutants in yeast have been characterized for each step of the CL

biosynthetic pathway, and mutants blocked earlier in the pathway have more
severe phenotypes. Thus, the pgs1Δ mutant, which cannot synthesize CL or the
precursor PG (Fig. 1.1), exhibits severe growth defects not only in nonfermentable carbon sources, which are metabolized by respiration, but also in
fermentable carbon sources, in which respiration is not required (Chang et al.,
1998a; Dzugasova et al., 1998). This observation indicated that PG and/or CL
are required for cellular functions apart from mitochondrial bioenergetics (Jiang et
al., 1999). Genetic studies to isolate spontaneous suppressors of the pgs1Δ
mutant growth defect identified a loss of function mutation of KRE5, a gene
involved in cell wall biogenesis (Zhong et al., 2005). Consistent with defective cell
wall biogenesis, the pgs1Δ mutant exhibited enlarged cell size characteristic of
cell wall mutants, reduced levels of β-1,3-glucan as a result of decreased activity
of glucan synthase, and sensitivity to cell wall perturbing agents (de Nobel et al.,
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2000; Popolo et al., 1993; Zhong and Greenberg, 2005). These defects were
restored by disruption of KRE5 in pgs1Δ, which increased expression of the
genes FKS1 and FKS2 encoding glucan synthase (Zhong et al., 2007). These
findings were in agreement with the identification of PGS1 in a screen to identify
genes involved in cell wall biogenesis (Lussier et al., 1997).
Studies to gain insight into the mechanism linking CL to the cell wall
focused on the PKC-Slt2 cell integrity pathway. Activation of the cell integrity
pathway is triggered by signals generated from cell wall sensor proteins to Rom2,
which, in turn, activates formation of the GTP-bound form of Rho1p. The
activated Rho1 protein transmits a signal to Pkc1 to trigger the Mpk1/Slt2 MAPK
signaling cascade, which results in dual phosphorylation of Slt2 (Heinisch et al.,
1999; Levin, 2005). The dual phosphorylation of Slt2 is essential to activate
transcription factors that up-regulate genes involved in cell wall remodeling,
particularly in response to heat stress (de Nobel et al., 2000; Jung and Levin,
1999; Terashima et al., 2000). The pgs1Δ mutant exhibited defective activation of
the PKC-Slt2 cell-integrity signaling cascade, indicated by decreased Slt2
phosphorylation levels (Zhong et al., 2007). Consistent with this, overexpression
of individual genes in the PKC- Slt2 pathway rescued the growth defect of pgs1Δ
at elevated temperature and improved resistance to the cell wall perturbing
chemicals calcofluor white and caffeine. Interestingly, deletion of KRE5 in pgs1Δ
also led to increased activation of the PKC-Slt2 cell-integrity pathway.
A mitochondrial connection to the cell wall is not new. Genome-wide
screens have identified several yeast genes required for mitochondrial function
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that, when mutated, affect chemical components of the cell wall (Conde et al.,
2003; Lussier et al., 1997; Page et al., 2003). Furthermore, mitochondrial
respiratory defects negatively impact the synthesis of cell wall components
(Lussier et al., 1997; Page et al., 2003). The underlying mechanism whereby CL
regulates cell wall remodeling is not known. One possibility is that CL is required
for activity of one or more proteins that exhibit dual localization in the cell
wall/plasma membrane and mitochondria (Velours et al., 2002). Interesting
possibilities include three proteins of the PKC-Slt2 cell integrity pathway, Fks1,
Zeo1 and Rho1, which are found both in the mitochondria and the plasma
membrane (Green et al., 2003; Sickmann et al., 2003; Zahedi et al., 2006).
Mitochondrial targeting of these proteins may be CL-dependent. Alternatively,
their stability in the mitochondrial membrane may be decreased in the absence of
CL.
The yeast cell wall also plays an important role in regulating replicative life
span (Kaeberlein and Guarente, 2002). Consistent with this, the pgs1Δ mutant,
which exhibits cell wall defects, also has a decreased replicative life span (Zhong
et al., 2005; Zhou et al., 2009). Intriguingly, experiments to elucidate the
mechanism linking PG/CL to defects in the cell wall, PKC/Slt2 signaling and
aging led to another signaling pathway – the HOG stress response pathway.

6.

CL and the HOG stress response pathway:
In response to stress, cells are regulated by the opposing actions of the

PKC-Slt2 and HOG signaling pathways (Hahn and Thiele, 2002; Hayashi and
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Maeda, 2006; Winkler et al., 2002). Heat or low osmolarity stress leads to
activation of the PKC-Slt2 pathway, resulting in increased expression of the cell
wall remodeling genes leading to a decrease in turgor pressure (Davenport et al.,
1995; Garcia-Rodriguez et al., 2005; Hohmann, 2002). In contrast, activation of
the HOG signaling pathway causes an increase in turgor pressure (Hohmann,
2002; Rep et al., 2000). Because the pgs1Δ mutant exhibited defective activation
of the PKC-Slt2 signaling cascade, it was hypothesized that growth defects of the
mutant resulted from increased turgor pressure, which may be rescued by downregulation of the HOG pathway (Fig. 1.3) (Zhou et al., 2009). This hypothesis
was supported by the finding that deletion of SHO1, an upstream activator of
HOG signaling, rescued growth defects, increased the replicative life span, and
alleviated sensitivity to cell wall perturbing agents in pgs1Δ (Zhou et al., 2009).
Interestingly, the mutant did not exhibit increased activation of the HOG pathway.
It is possible that, in the absence of PKC-Slt2 activation, even wild type levels of
HOG activation lead to turgor pressure levels that affect growth. These findings
suggest that homeostasis achieved by these two signaling pathways is perturbed
upon CL deficiency (Fig. 1.3).

7.

CL mediates cross-talk between mitochondria and vacuole:
The yeast crd1Δ mutant, which lacks CL, was shown to have defective

vacuolar function (Chen et al., 2008b). CL deficiency caused decreased VATPase activity and proton pumping, reduced vacuolar acidification, and
enlargement of the vacuole. The yeast vacuole plays a crucial role in adjusting to
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Figure 1.3. CL deficiency leads to perturbation of PKC-Slt2 and HOG
signaling pathways. The PKC-Slt2 and HOG signaling pathways coordinately
regulate cell wall biogenesis and intracellular turgor pressure, respectively. Under
hypertonic or cold stress conditions, extracellular osmolarity is increased,
causing an efflux of intracellular water to reduce the turgor pressure on the cell
wall. To counteract augmented extracellular osmolarity, the HOG pathway is
activated, which leads to an increase in intracellular turgor pressure. In contrast,
under heat or hypotonic stress, extracellular osmolarity is decreased, which
causes an influx of water inside the cell to increase intracellular turgor pressure.
To counteract the increased turgor pressure, the activated PKC-Slt2 pathway
induces cell wall synthesis. We hypothesize that disruption of the CL pathway by
mutation of PGS1 generates a signal that is detected by regulators or
components of the PKC-Slt2 pathway, which, in turn, down-regulates the
pathway. Under these conditions, an increase in intracellular turgor pressure by
activation of the HOG pathway is deleterious in pgs1Δ cells.
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high external osmolarity and decreased turgor pressure, and in maintaining
cytosolic ion concentrations (Klionsky et al., 1990; Latterich and Watson, 1993).
Consistent with perturbation of intracellular osmotic balance in the crd1Δ mutant,
growth and vacuolar defects were rescued by supplementation of sorbitol (Chen
et al., 2008b).
In some genetic backgrounds, the crd1Δ mutant exhibits increased
expression of RTG2, a critical sensor of mitochondrial dysfunction that relays
metabolic defects to the nucleus via the retrograde signaling pathway (Butow and
Avadhani, 2004; Liu and Butow, 2006). Consistent with overactivation of Rtg2,
deletion of the RTG2 gene restored vacuolar acidification and V-ATPase activity
and rescued the growth defect of the crd1Δ mutant at elevated temperature.
However, deletion of the retrograde pathway activator RTG3 did not rescue the
mutant, suggesting that the defects observed in crd1Δ resulted from Rtg2
functions unrelated to retrograde activation.
One possible explanation for the vacuolar defects in crd1Δ is that the loss
of CL leads to intracellular osmotic imbalance, as suggested by the enlarged cell
size of the mutant (Fig. 1.4). Consistent with this, deletion of the NHX1 gene (but
not any of the other vacuole ion transporters) in crd1Δ restored vacuolar
morphology to wild type levels (Chen et al., 2008b). Nhx1 is the Na+/H+
exchanger located in late endosomal/prevacuolar membranes, and is involved in
the export of protons in exchange for cytosolic Na+ or K+ (Ali et al., 2004; Brett et
al., 2005).
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Figure 1.4. Proposed models to explain the role of CL in vacuolar function.
It is likely that CL is transported to the vacuole through mitophagy, the selective
degradation of mitochondria via the autophagosome, which delivers its cargo to
the vacuole. (A) Under normal physiological conditions, CL may provide stability
to the V-ATPase, which is essential to maintain its activity. (B) CL deficiency may
lead to perturbation of mitophagy, which results in decreased delivery of CL to
the vacuole and, subsequently, to destabilization of the V-ATPase, decreased
ATPase activity, and enlargement of the vacuole.
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Another possibility is that CL may regulate vacuolar function by directly
activating the V-ATPase (Fig. 1.4). While CL is predominantly found in the
mitochondrial membranes, significant amounts are also detected in the vacuolar
membrane, and the levels vary depending on the carbon source of the growth
media (Zinser et al., 1991). How does CL, which is synthesized in the
mitochondria, get to the vacuole? The most likely mechanism is via selective
degradation of the mitochondria by the autophagic process known as mitophagy,
which is strongly induced in yeast by nutrient starvation and during the stationary
growth phase (Kanki et al., 2009; Komatsu et al., 2005; Lemasters, 2005;
Shintani et al., 2002; Takeshige et al., 1992; Tal et al., 2007). CL that has
integrated into the vacuolar membrane as a result of mitophagy may directly
activate the V-ATPase and/or stabilize the protein. This possibility is highly
speculative at this stage, as such interactions have not yet been reported.
Cross-talk between mitochondria and vacuole is further supported by a
recent finding, which showed that the vacuolar pH is a determinant of
mitochondrial function and aging in yeast cells (Hughes and Gottschling, 2012).
Aging yeast cells exhibit a decline in vacuolar acidity, which causes mitochondrial
dysfunction and a decrease in replicative life-span (Hughes and Gottschling,
2012). Consistent with this, enhancing vacuolar acidity by overexpressing VMA1
or VPH2, which encode proteins that regulate V-ATPase activity, suppressed
mitochondrial dysfunction. The mechanisms underlying the interplay between
vacuole and mitochondria, and the role of CL in this process, remain to be
elucidated.
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8.

CL and iron homeostasis:
In addition to the cellular functions mentioned above, our recent studies,

which are the focus of this dissertation, suggest that CL is required for
maintaining mitochondrial and cytosolic iron homeostasis (Patil et al., 2012). Iron
is an essential metal that is utilized for the synthesis of two crucial cellular
components, heme and iron-sulfur (Fe-S) clusters (Kaplan et al., 2006; Ye and
Rouault, 2010). Both heme and Fe-S clusters are incorporated into proteins that
participate in cellular functions that include respiration, DNA replication, and
synthesis of cholesterol and amino acids (Philpott et al., 2012; Shakoury-Elizeh
et al., 2010).
Iron exists in two oxidation states; in the ferric (Fe3+) form it is insoluble
whereas in the ferrous (Fe2+) form it is highly reactive. While sufficient iron is
essential, excess iron is extremely toxic (Hentze et al., 2004). Therefore, cellular
iron must be constantly chaperoned, and its acquisition and transport tightly
regulated. To acquire iron, yeast employs high and low affinity iron uptake
systems, which are collectively referred, the iron regulon (Kosman, 2003).
Expression of the iron regulon is controlled by the iron-responsive transcription
factors Aft1 and its paralogue, Aft2 (Rutherford and Bird, 2004; Rutherford et al.,
2003; Yamaguchi-Iwai et al., 1995). Aft1 and Aft2 are the direct sensors of
mitochondrial Fe-S biogenesis, and they respond to iron deficiency or impairment
of mitochondrial Fe-S clusters by up-regulating the iron regulon, which leads to
an increase in iron-uptake (Hausmann et al., 2008; Kaplan et al., 2006).
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Fe-S cluster biogenesis in the mitochondria occurs via a complex pathway
composed of two stages (Rawat and Stemmler, 2011). First, Fe-S clusters are
assembled on the Isu scaffold, process in which iron (Fe) is delivered by Yfh1
and sulfur (S) is provided by the Nfs1-Isd11 complex. Second, the 2Fe-2S
clusters formed on Isu1 are transferred to apoenzymes to form holoenzymes by
a process catalyzed by Ssq1/Grx5/Jac1/Mge1 proteins.
The optimal function of several mitochondrial Fe-S proteins, including
aconitase and succinate dehydrogenase of the TCA cycle and respiratory
complex III, depends on Fe-S biogenesis (Gerber et al., 2004; Lange et al., 2000;
Muhlenhoff et al., 2002). Similarly, mitochondrial Fe-S biogenesis is also required
for the maturation of cytosolic Fe-S proteins, as cytosolic Fe-S assembly
depends on Fe-S co-factors synthesized in the mitochondria (Gerber et al., 2004;
Lange et al., 2000; Muhlenhoff et al., 2002). Perturbations of mitochondrial Fe-S
biogenesis also lead to defective maturation of cytosolic Fe-S proteins. The
studies described in chapter two demonstrate that CL deficiency leads to
perturbation of mitochondrial Fe-S biogenesis, which results in decreased activity
of both mitochondrial and cytosolic Fe-S proteins.

9.

Project outline:
Although disruption of CL synthesis due to mutations in tafazzin leads to

BTHS, it is unclear how CL deficiency contributes to the pathology observed. As
discussed above, studies primarily in yeast have enhanced our understanding of
the cellular role of CL. Yet, very little is known of the biochemical processes that
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are disrupted in BTHS patients. To gain insight into CL functions that might
explain the pathology and the variable clinical phenotypes observed in BTHS,
genome-wide expression profiling was carried out in the yeast CL mutant crd1Δ.
The most intriguing finding in this study was increased expression of the iron
uptake genes in the mutant, suggesting either iron deficiency or perturbation of
processes involving mitochondrial Fe-S cluster biogenesis and/or export of extramitochondrial Fe-S co-factors.
The data presented in chapter two demonstrates that CL deficiency leads
to perturbation of iron homeostasis due to defective Fe-S cluster biogenesis in
the mitochondria. As an indication of this, the crd1Δ mutant exhibits elevated
mitochondrial iron levels along with decreased activity of enzymes that contain
Fe-S clusters. The synthetic genetic interaction of crd1Δ with the mitochondrial
Fe-S scaffolding protein Isu1 suggests that the underlying mechanism for
perturbation of iron homeostasis is defective synthesis of Fe-S clusters. These
findings suggest that iron homeostasis could be an important physiological
modifier that contributes to the phenotypes observed in BTHS patients.
Because the synthesis of several amino acids is dependent on Fe-S
enzymes, perturbation of Fe-S biogenesis would be predicted to cause amino
acid deficiencies. The data presented in chapter three show that a decrease in
the activities of Fe-S enzymes aconitase and sulfite reductase in crd1Δ leads to
auxotrophies for both glutamate and cysteine. Interestingly, these two amino
acids are required for the synthesis of an essential antioxidant, glutathione
(GSH), a tripeptide of glutamate, cysteine, and glycine. Consistent with
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decreased synthesis of GSH, the growth defect of crd1Δ at elevated temperature
is rescued by GSH supplementation. These findings suggest that the underlying
mechanism for GSH deficiency in crd1Δ is defective mitochondrial Fe-S
biogenesis, which results in depletion of precursors for GSH synthesis.
In order to identify the cellular functions that are perturbed in the absence
of CL, a screen of suppressors of the crd1Δ mutant was carried out, which is
described in chapter four. Briefly, the yeast genomic DNA library was
overexpressed in crd1Δ to identify genes that restore the growth of crd1Δ at
elevated temperature. In this screen, 50 putative suppressors of crd1Δ were
obtained. Interestingly, one of the suppressor genes was LEU2, which encodes
an enzyme involved in leucine biosynthesis, a process that is perturbed in crd1Δ
(described in chapter two). This supports the finding that perturbation of leucine
synthesis likely contributes to the growth defect of crd1Δ.
Although the data presented in this thesis describe new cellular functions
of CL, the mechanism underlying the role played by CL in these processes
remains to be answered. These questions and future studies are described in
chapter five.
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CHAPTER 2

LOSS OF CARDIOLIPIN LEADS TO PERTURBATION OF MITOCHONDRIAL
AND CELLULAR IRON HOMEOSTASIS
The work described in this chapter has been published in the Journal of
Biological Chemistry, 288(3): 1696-1705, 2013.
INTRODUCTION

Cardiolipin (CL) is a structurally and functionally unique phospholipid that
is almost exclusively present in mitochondrial membranes (Schlame and Ren,
2009; Schlame et al., 2000). The presence of CL is critical for maintaining
mitochondrial function, structure, and membrane fluidity. Perturbation of CL
synthesis alters mitochondrial bioenergetics, resulting in reduced membrane
potential, inefficient coupling of respiration, and decreased ATP synthesis
(Claypool et al., 2008; Jiang et al., 2000; Koshkin and Greenberg, 2000; Koshkin
and Greenberg, 2002). In the inner membrane, CL is tightly associated with
several proteins in respiratory complexes I, III, and IV (Joshi et al., 2009). CL is
essential for the stability of respiratory chain supercomplexes which, in yeast, are
comprised of dimeric ubiquinol-cytochrome c oxidoreductase (complex III) and
one or two complexes of cytochrome c oxidase (complex IV) (Cruciat et al., 2000;
Pfeiffer et al., 2003; Zhang et al., 2002b). Perturbation of CL synthesis due to
mutations in the CL remodeling enzyme tafazzin causes the severe human
genetic disorder known as Barth syndrome (BTHS) (Bione et al., 1996b).

30
Tafazzin (Taz1) deficiency in yeast leads to biochemical and bioenergetic defects
similar to those seen in BTHS patients (Brandner et al., 2005; Gu et al., 2004; Ma
et al., 2004; McKenzie et al., 2006).
While perturbation of CL synthesis due to loss of tafazzin leads to cardioand skeletal myopathy, neutropenia, and growth retardation in BTHS (Barth et
al., 1999b), the clinical presentation of this disorder is highly variable, ranging
from neonatal death to lack of clinical symptoms (Barth et al., 1999b; Bleyl et al.,
1997). In order to gain insight into CL functions that might explain the pathology
and variable phenotypes observed in BTHS, we carried out a genome-wide
expression analysis in the yeast CL mutant crd1Δ, which lacks CL synthase. The
most striking alterations in gene expression were observed in iron uptake genes.
These genes encode components of the yeast high- and low-affinity iron uptake
systems, collectively referred to as the iron regulon (Kosman, 2003). Because
the gene expression analyses indicating elevated expression of the iron regulon
were carried out in iron-replete conditions, we hypothesized that CL might be
required for mitochondrial Fe-S biogenesis and/or export of mitochondrial Fe-S
co-factors to the cytosol, two processes known to induce upregulation of the iron
regulon (Hausmann et al., 2008; Rutherford et al., 2005).
The assembly of Fe-S clusters from ferrous (Fe2+) and sulfide (S2-) ions
does not occur spontaneously in living cells, as unchaperoned iron and sulfur are
toxic. Rather, cells utilize a complex Fe-S assembly and transport process that is
highly conserved from yeast to humans (Lill and Muhlenhoff, 2006). The
assembly of Fe-S clusters in the mitochondria begins on the highly conserved
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scaffolding protein Isu1 and its homolog Isu2 (Muhlenhoff et al., 2003). The Nfs1Isd11 complex delivers sulfur (Muhlenhoff et al., 2004; Zheng et al., 1994), and
Yfh1 donates iron (Fe2+) to the Isu scaffold (Zhang et al., 2006). This process
also includes ferredoxin (Arh1) and ferredoxin reductase (Yah1), which provide
electrons for the reduction of sulfur to sulfide (Lange et al., 2000; Li et al., 2001).
The Fe-S clusters assembled on the scaffold are transferred to the recipient
apoproteins, in a process that is assisted by several proteins localized in the
mitochondrial matrix (Lill and Muhlenhoff, 2006).
Mitochondria also possess Fe-S export machinery, which transports an
unknown Fe-S component from the mitochondria that is matured by the cytosolic
machinery into 4Fe-4S clusters (Kispal et al., 1999; Lange et al., 2001b; Rissler
et al., 2005). The mitochondrial Fe-S export machinery includes the ABC
transporter Atm1 in the inner membrane and the sulfhydryl oxidase Erv1 in the
intermembrane space. Perturbations in mitochondrial Fe-S assembly or Fe-S
export machinery are known to induce expression of the Aft1/Aft2-regulated iron
uptake genes, leading to increased mitochondrial iron levels. Defects in
mitochondrial Fe-S assembly lead to decreased maturation of both mitochondrial
and cytosolic Fe-S proteins (Gerber et al., 2004; Hausmann et al., 2008; Kaut et
al., 2000; Kispal et al., 1999; Li et al., 1999; Muhlenhoff et al., 2002). In addition,
excess mitochondrial iron causes oxidative damage to Fe-S clusters due to the
formation of reactive oxygen species (ROS) (Bulteau et al., 2007; MorenoCermeno et al., 2010; Vasquez-Vivar et al., 2000).
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In the current study, we show that crd1Δ cells exhibit perturbations in iron
homeostasis, including increased expression of the iron uptake genes, elevated
mitochondrial iron levels, and growth sensitivity to both FeSO4 supplementation
and the ROS inducing agent H2O2. We further demonstrate that the loss of CL
leads to decreased activities of both mitochondrial and cytosolic Fe-S enzymes,
suggesting that the mechanism underlying altered iron homeostasis is
perturbation of Fe-S biogenesis. Consistent with this conclusion, crd1Δ cells
exhibit a synthetic genetic interaction with the Fe-S scaffolding protein Isu1.
Additionally, the iron homeostasis defects in crd1Δ are not rescued by
overexpression of ATM1, the major component of mitochondrial Fe-S export
machinery, which is activated by CL (36), nor is it rescued by overexpression of
YAP1, which regulates expression of antioxidant genes (Inoue et al., 1999; Lee
et al., 1999; Sugiyama et al., 2000). Overexpression of ATM1 and YAP1 might
reasonably be expected to overcome defective Fe-S cluster export from
mitochondria. However, overexpression did not rescue the mutant defects,
suggesting that the loss of CL affects the process of mitochondrial Fe-S
biogenesis. This study is the first to demonstrate that CL is required for Fe-S
cluster biogenesis and for the maintenance of mitochondrial and cellular iron
homeostasis.

33
MATERIALS AND METHODS

Yeast strains and growth media
The yeast Saccharomyces cerevisiae strains used in this work are listed in
Table 1. Synthetic defined (SD) medium contained adenine (20.25 mg/l), arginine
(20 mg/l), histidine (20 mg/l), leucine (60 mg/l), lysine (20 mg/l), methionine (20
mg/l), threonine (300 mg/l), tryptophan (20 mg/l), and uracil (20 mg/l), yeast
nitrogen base without amino acids (Difco, Detroit, MI), and carbon source
(fermentative) glucose (2%) or (respiratory) glycerol (3%) plus ethanol (0.65%) or
(respiro-fermentative) galactose (2%). SD-drop out medium contained all of the
above-mentioned ingredients except for the indicated amino acid. For growth
experiments on excess iron, 1 µM CuSO4 was used and FeSO4 was solubilized
in 0.1 N HCl, filter-sterilized and added to the culture medium at the indicated
concentration. Complex media (YPD or YP-gal) contained yeast extract (1%),
peptone (2%), and either glucose (2%) or galactose (2%) as indicated.
Deletion mutants were constructed by replacing the entire open reading
frame of the target gene with the KanMX4 cassette by homologous
recombination. The KanMX4 cassette was amplified from the pUG6 plasmid
using primers consisting of 51 nucleotides identical to the target gene flanking
regions at the 5’ end and 21 nucleotides for the amplification of the KanMX4
gene at the 3’ end. The PCR product was transformed by electroporation into
cells, and transformants were selected on YPD media containing G418 (300
µg/ml). Disruption of the target gene was confirmed by PCR using primers
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Table 2.1. Yeast strains and plasmids used in this study.
Strain

Genotype

Source or reference

FGY3

MATa, ura3-52, lys2-801, ade2-101, trp1-Δ1, his3Δ200, leu2-Δ1
MATa, ura 3-52, lys2-801, ade2-101, trp1-Δ1,
his3-Δ200, leu2-Δ1, crd1Δ::URA3
MATa, ura 3-52, lys2-801, ade2-101, trp1-Δ1,
his3-Δ200, leu2-Δ1, isu1Δ::KanMX4
MATa, ura 3-52, lys2-801, ade2-101, trp1-Δ1,
his3-Δ200,
leu2-Δ1,
crd1Δ::URA3,
isu1Δ::KanMX4
MATa, ura 3-52, lys2-801, ade2-101, trp1-Δ1,
his3-Δ200, leu2-Δ1, isu2Δ::KanMX4
MATa, ura 3-52, lys2-801, ade2-101, trp1-Δ1,
his3-Δ200,
leu2-Δ1,
crd1Δ::URA3,
isu2Δ::KanMX4
Low-copy number plasmid, TRP1 nutritional
marker
Derivative of pCM182, expresses ISU1 from the
TETOFF promoter
Low-copy number plasmid, LEU2 nutritional
marker
High-copy number plasmid, LEU2 nutritional
marker
Derivative of YEp351, expresses YAP1 from the
native promoter

(Jiang et al., 1997)

FGY2
FGY3 isu1Δ
FGY2 isu1Δ
FGY3 isu2Δ
FGY2 isu2Δ
pCM182
pCM182ISU1
pRS415
YEp351
YEp351YAP1

(Jiang et al., 1997)
This study
This study

This study
This study
ATCC®
87656
This study

Number:

(Zhong et al., 2004)
(Hill et al., 1986)
(Wemmie et al., 1994)
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against the target gene coding sequences.

Plasmid construction and cloning
To construct the ISU1-overexpressing plasmid, a 538-bp sequence
containing the entire open reading frame of ISU1 was amplified from yeast
genomic

DNA

using

BamHI-tagged

primer

ISU1-BamHIF

(5-

GGAAAACACAACGGATCCCACATATTTAACC-3) and PstI-tagged primer ISU1PstIR (5-GATCTTGTTCTGCAGCCGGTTATCTTCTT-3). Similarly, a 2098 bp
sequence containing the entire open reading frame of ATM1 was amplified using
NotI-tagged

primer

ATM1-NotIF

(5-

TTGATAGATGCGGCCGCAACCTGCAAATG-3) and PstI-tagged primer ATM1PstIR (5-TACATGTCTGCAGCAATATTTACTTACGAGCG-3). The PCR products
were ligated to pCM182 (a low-copy number plasmid with selectable marker
TRP1) downstream of the TETOFF promoter. All the plasmids were amplified and
extracted using standard protocols. The plasmids were transformed into yeast
strains using the yeast one-step transformation protocol (Chen et al., 1992). A
high-copy number YEp351-YAP1 overexpression plasmid was a kind gift from W.
Scott Moye-Rowley (Univ. of Iowa) (Wemmie et al., 1994).

Microarray analysis
Yeast cells were grown to the early stationary phase in YPD, and total
RNA was isolated by hot phenol extraction (Kohrer and Domdey, 1991). RNA
was further purified using an RNeasy kit from Qiagen. Yeast 6.4k microarray
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slides containing 6240 different yeast expressed sequence tags (double spotted)
were purchased from University Health Network (Toronto, M5G 2C4). Synthesis
of Cy3- or Cy5-labeled cRNA and hybridization were performed using SlideHyb
#1 buffer (Ambion) at the Research Technology Support Facility at Michigan
State University (East Lansing, MI). The glass slides were scanned with an
Affymetrix 428 Array Scanner and quantified using GenePix Pro 3.0 software
(Axon). Array normalization and statistical analysis were performed using the
“limma: Linear Models for Microarray Data” library module (version 2.2.0) of the
R statistical package (version 2.2.0) (R_Development_Core_Team, 2005; Smyth,
2005; Smyth, 2004; Smyth et al., 2005; Smyth and Speed, 2003). Slide intensity
data was normalized using the global loess method. The least squares method
was used for the linear model fit utilizing the Benjamini and Hochberg method to
control the false discovery rate. Each experiment was repeated once with
switched Cy3- and Cy5-labeling. The average of the 4 signal log ratios of each
gene was computed and converted to a fold change. The raw data can be
downloaded

from

the

Gene

Expression

Omnibus

(http://www.ncbi.nlm.nih.gov/geo, GPL3464).

Quantitative PCR (qPCR) analysis
Yeast cultures (10 ml) were grown to the logarithmic growth phase, cells
were harvested, and total RNA was isolated using the RNeasy Plus Mini kit from
Qiagen. The cDNAs were synthesized with Transcriptor First Strand cDNA
Synthesis Kit (Roche Diagnostics), and quantitative PCR reactions were
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performed in a 25-µl volume using Brilliant™ SYBR® Green QPCR Master Mix
(Stratagene) in a 96-well plate. Duplicates were included for each reaction. The
primers used for qPCR are listed in Table 2.2. ACT1 was used as the internal
control, and the RNA level of the gene of interest was normalized to ACT1 levels.
PCR reactions were initiated at 95°C for 10 min for denaturation followed by 40
cycles consisting of 30 s at 95°C and 60 s at 55°C.

Biochemical assays and measurement of mitochondrial metal ion content
Mitochondria were isolated from cell lysates prepared as previously
described (Diekert et al., 2001). Briefly, spheroplasts obtained by zymolase
treatment were disrupted by Dounce homogenization, and mitochondria were
isolated by differential centrifugation. Total protein concentration was determined
with a Bradford assay kit (BioRad), with BSA as the standard. The following
assays were performed in isolated mitochondria. Succinate dehydrogenase
activity was assayed by determining succinate-dependent reduction of 2,6dichlorophenol-indolphenol (DCPIP). The absorbance decrease at A600 was
recorded as a reporter of decylubiquinone reduction (Pierik et al., 2009).
Ubiquinol-cytochrome c oxidoreductase activity was assayed by monitoring
reduction of cytochrome c at A550 (Atkinson et al., 2011).
Cell extracts were prepared by resuspending cells in 500 µl TNTEG buffer
(10 mM Tris-Cl pH 7.4, 2.5 mM EDTA, 150 mM NaCl, 10% v/v glycerol, 0.5% v/v
Triton X-100) and subjecting them to mechanical breakage with glass beads. Cell
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Table 2.2. Primers used for qPCR analyses.
Gene
ACT1

Primer
Forward
Reverse
AFT1 Forward
Reverse
FIT1
Forward
Reverse
FIT2
Forward
Reverse
FIT3
Forward
Reverse
FET3 Forward
Reverse
FTR1 Forward
Reverse
ARN1 Forward
Reverse
ARN2 Forward
Reverse
ARN3 Forward
Reverse

Sequence
TCGTGCTGTCTTCCCATCTATCG
CGAATTGAGAGTTGCCCCAGAAG
ATGCATCTAAAAGGCCATGC
ACTGGCTTTTCGGTTTCCTT
CCACCTCCTCTGAGTCAAGC
CAGATTGGGCATCCCTAGAA
ACAAAGGTTGTCACCGAAGG
TGAACCTGAACCGTTTGTCA
GCTACATCCTCTAGCACCGC
GCACCCATCAAACCAGTACC
ACAGTTTCGATCCGGACAAC
CACCTGGGTTATCGGCTTTA
GATTCAACCTTGCCAGTGGT
ATTGTCCAGTTCTGGGTTGC
CTCGCGATCCTGTTAAGGAG
GGGAGACCATATGAGTCGGA
TGTGGGACTTGTCGGTGTTA
GGGCCATGAAGGTATCAATG
TGGATTAGCGGGAACGTAAC
GGAATACAAGCTAGCGGCAG
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debris and unbroken cells were separated by low speed centrifugation (2000 g
for 5 min at 4 °C). The obtained supernatant was further centrifuged at 13,000 g
for 10 min and the resulting supernatant was transferred to a new tube. Total
protein concentration was determined as mentioned above. The following
enzyme assays were performed in whole-cell extracts. Aconitase was assayed
by the aconitase-isocitrate dehydrogenase coupled assay, in which NADPH
formation was monitored at A340 (Pierik et al., 2009). Sulfite reductase was
assayed by monitoring methylene blue formation at A670 from sulfide produced by
NADPH-dependent sulfite reduction (Pierik et al., 2009; Rutherford et al., 2005).
Isopropylmalate

isomerase

was

assayed

by

monitoring

formation

of

isopropylmalate at A235 from dehydration of 3-isopropylmalate (Pierik et al.,
2009). Statistical significance of all enzyme assay results was determined by an
analysis of variance (ANOVA) and Bonferroni's posthoc test in KaleidaGraph. In
the isopropylmalate isomerase assay, because the parental strains carry the
leu2Δ null mutation, cells were transformed with a low/single copy pRS415
plasmid containing the LEU2 marker.
For the measurement of mitochondrial iron content, mitochondria were
further purified via ultracentrifugation through a discontinuous Histodenz (SigmaAldrich) gradient (14% and 22%). Mitochondria (0.25 mg mitochondrial protein)
were digested in 70% HNO3 by boiling for 2 min and then diluted to 30% HNO3.
Iron content was determined using an inductively coupled plasma-optical
emission spectrometer (ICP-OES).
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RESULTS

Loss of CL leads to increased expression of iron uptake genes:
In order to understand the cellular response to CL deficiency, we
performed a genome-wide microarray analysis in cells of the CL synthase mutant
crd1Δ, which completely lacks CL (Chang et al., 1998b; Jiang et al., 1997; Tuller
et al., 1998). The microarray analysis revealed increased expression of genes
involved in iron homeostasis in the crd1Δ mutant (Patil et al., 2012). To confirm
the effect of loss of CL on expression of the iron regulon genes, we carried out
quantitative PCR analysis of the Aft1-regulated iron uptake genes in crd1Δ. Cells
were grown in SD respiratory media to the logarithmic growth phase and RNA
was extracted for mRNA quantitation, as described in the “Materials and
Methods.” As seen in Fig. 2.1, the mRNA levels of AFT1, FIT1-3, FET3, FTR1
and ARN1-3 were upregulated more than 3-fold in crd1Δ. Up-regulation of AFT1
and the iron regulon genes in the crd1Δ mutant suggested either deficient cellular
iron levels or perturbation of mitochondrial Fe-S cluster biogenesis, and/or export
of extra-mitochondrial Fe-S co-factors are perturbed in this mutant (Chen et al.,
2004; Hausmann et al., 2008; Kispal et al., 1999).

Perturbation of iron homeostasis in crd1Δ:
We quantified mitochondrial iron using ICP-OES (inductively coupled
plasma-optical emission spectroscopy) and found that iron levels in the crd1Δ
mutant were significantly increased by 33% relative to WT levels (Fig. 2.2). This
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Figure 2.1. Increased expression of the iron regulon in crd1Δ. The mRNA
levels of iron regulon genes were quantified by qPCR from cells grown in SD
glycerol-ethanol at 30°C to the logarithmic phase. Values are reported as fold
change in expression over WT. Expression was normalized to the mRNA levels
of the internal control ACT1. Data shown are mean ± SE (n=6).
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Figure 2.2. Increased mitochondrial iron levels in crd1Δ. (This experiment
was carried out in the laboratory of Dr. Dennis R. Winge, University of Utah
Health Sciences Center) Cells were grown in YP-galactose at 30°C to the
logarithmic phase, and mitochondrial iron levels were determined by ICP-OES.
Data shown are mean ± SE (n=9). The asterisk indicates a significant difference
relative to WT.
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result suggested that the iron regulon in crd1Δ is upregulated for a reason other
than low cellular iron levels. Previous studies have reported that mutations in
yeast genes involved in Fe-S cluster synthesis or in the export of Fe-S co-factors
lead to elevated mitochondrial iron levels (Garland et al., 1999; Hausmann et al.,
2008; Kispal et al., 1997; Knight et al., 1998; Li et al., 1999; Muhlenhoff et al.,
2002).
Perturbation of mitochondrial Fe-S biogenesis leads to growth sensitivity
in the presence of FeSO4 (Foury, 1999; Foury et al., 2007; Leidgens et al., 2010;
Ramazzotti et al., 2004). As seen in Fig. 2.3B-C, crd1Δ cells showed growth
sensitivity to 5 mM and 10 mM FeSO4. This sensitivity to iron supplementation
was observed when crd1Δ cells were grown in galactose (respiro-fermentative)
and ethanol (respiratory) but not in glucose (fermentable) media (Fig. 2.3A). This
is most likely because cells have a greater demand for iron in respiratory and
respiro-fermentative media, in order to synthesize heme and Fe-S containing
proteins involved in oxidative phosphorylation (Garber Morales et al., 2010;
Kaplan et al., 2006).
Increased mitochondrial iron levels cause hypersensitivity to oxidative
stress (Babcock et al., 1997; Muhlenhoff et al., 2002; Schilke et al., 1999), which
may be reflected in sensitivity to ROS inducing agents. Consistent with increased
oxidative stress, crd1Δ cells exhibited increased sensitivity to the ROS-inducing
agent H2O2 (Fig. 2.3D). In summary, the absence of CL leads to increased
mitochondrial iron levels as well as sensitivity to iron supplementation and
oxidative stress, consistent with perturbation of iron homeostasis.
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Figure 2.3. Sensitivity of crd1Δ to iron and H2O2. Cells were precultured in
YPD overnight, serially diluted, spotted on SD plates containing (A) glucose +
FeSO4, (B) galactose + FeSO4, (C) ethanol + FeSO4, and (D) galactose + H2O2,
and incubated at 30°C for 5 days.
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Fe-S deficiencies in crd1Δ:
We explored the possibility that the iron homeostasis defects in the crd1Δ
mutant resulted from perturbation of Fe-S biogenesis. Perturbation of
mitochondrial Fe-S assembly has been shown to cause decreased activity of
mitochondrial proteins containing Fe-S clusters (Gerber et al., 2004; Lange et al.,
2000; Muhlenhoff et al., 2002). To this end, we assayed the activities of the Fe-S
enzymes succinate dehydrogenase, ubiquinol-cytochrome c oxidoreductase, and
aconitase in crd1Δ. As seen in Table 2.3, these enzyme activities were
decreased by approximately 36%, 45%, and 78% respectively, in the crd1Δ
mutant. In addition, cytochrome c oxidase activity was decreased by 30% in the
crd1Δ mutant (data not shown), consistent with previous studies (Fry and Green,
1980; Jiang et al., 2000; Robinson, 1993; Sedlak and Robinson, 1999). The
decreased activities of mitochondrial Fe-S proteins in crd1Δ are not due to
reduced transcription of SDH2, RIP1, and ACO1 (Patil et al., 2012). These
results indicate that CL is required for the activity of mitochondrial Fe-S proteins
present in the inner membrane and matrix.
Mitochondrial Fe-S cluster biogenesis is also required for the maturation of
cytosolic Fe-S proteins, as cytosolic Fe-S assembly depends on Fe-S co-factors
synthesized in the mitochondria (Gerber et al., 2004; Kispal et al., 1999; Lange et
al., 2000; Muhlenhoff et al., 2002). To determine the impact of CL deficiency on
the activities of cytosolic Fe-S proteins, we measured the activities of sulfite
reductase,

which

catalyzes

the

conversion

of

sulfite

to

sulfide,

and

isopropylmalate isomerase, which catalyzes the inter-conversion of alpha-
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isopropylmalate and beta-isopropylmalate (Hsu and Schimmel, 1984; Masselot
and De Robichon-Szulmajster, 1975; Masselot and Surdin-Kerjan, 1977; Skala et
al., 1991). Sulfite reductase and isopropylmalate isomerase each contain a 4Fe4S cluster (Balk et al., 2005; Crane et al., 1997; Yoshimoto and Sato, 1968). As
seen in Table 2.3, sulfite reductase activity was decreased by ~46% in crd1Δ.
Because sulfite reductase is required for the synthesis of methionine and
cysteine, a decrease in activity would be expected to lead to methionine
auxotrophy. As seen in Fig. 2.4A, crd1Δ was auxotrophic for methionine at
elevated temperature. The crd1Δ mutant also exhibited a ~49% decrease in
activity of the leucine biosynthetic pathway enzyme isopropylmalate isomerase
(Table 2.3) along with leucine auxotrophy at elevated temperature (Fig. 2.4B).
These results indicate that the loss of CL also affects activity of Fe-S proteins in
the cytosol. Taken together, these experiments indicate that activities of both
mitochondrial and cytosolic Fe-S enzymes are affected by CL deficiency.

Genetic interaction between CRD1 and ISU1:
If CL is required for the biogenesis of Fe-S clusters in the mitochondria,
crd1Δ would be expected to be sensitive to further perturbation of Fe-S
biogenesis. Most of the genes involved in Fe-S cluster assembly, including
NFS1, ISD11, YAH1, and ARH1 are required for viability (Barros and Nobrega,
1999; Li et al., 1999; Manzella et al., 1998; Wiedemann et al., 2006). YFH1
deletion mutants are viable in some genetic backgrounds, but exhibit severe
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Table 2.3. Decreased mitochondrial and cytosolic Fe-S enzyme activities in
crd1Δ. Cells were grown in galactose medium and activities of Fe-S enzymes
were assayed as described in the ‘Materials and Methods’. Data shown are
mean ± SD (n≥4).
% activity in crd1Δ
relative to WT
Mitochondrial Fe-S enzymes
Succinate dehydrogenasec
Ubiquinol cytochrome c oxidoreductasec
Aconitasea

63.4 ± 9.5%
54.2 ± 13.8%
22.2 ± 13.89%

Cytosolic Fe-S enzymes
Sulfite reductase
Isopropylmalate isomeraseb

54.2 ± 1.81%
51.76 ± 9.27%

	
  

	
  

a

These cells were grown at 35°C. For sulfite reductase and isopropylmalate

isomerase assays, cells were grown in media lacking methionine and cysteine, or
leucine, respectively.
b
c

These cells were grown at 34°C.
These assays were carried out in the laboratory of Dr. Dennis R. Winge,

University of Utah Health Sciences Center.
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Figure 2.4. Methionine and leucine auxotrophy in crd1Δ. (A) Cells were
precultured overnight in galactose medium, serially diluted, spotted on SD
galactose media plates lacking methionine and incubated for 3-5 days. (B) Cells
were precultured overnight in galactose medium lacking leucine, serially diluted,
spotted on SD glucose plates lacking leucine and incubated for 3-5 days.
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growth defects (Lesuisse et al., 2003; Zhang et al., 2005b). However, ISU1 and
ISU2 both encode the mitochondrial Fe-S scaffolding protein and have
overlapping functions. Single mutants isu1Δ and isu2Δ do not show growth
defects, as the presence of either Isu1 or Isu2 is sufficient for survival, but
deletion of both genes is lethal (Gerber et al., 2004; Schilke et al., 1999). The
crd1Δisu1Δ double mutant showed a synthetic growth defect in galactose media,
but crd1Δisu2Δ grew normally (Fig. 2.5A). Isu1 is a more abundant scaffolding
protein than Isu2 (Andrew et al., 2008), which likely accounts for the more severe
phenotypic defect of the crd1Δisu1Δ mutant. To confirm that genetic defects
observed in the crd1Δisu1Δ double mutant are due to deletion of ISU1, we reintroduced ISU1 under the control of the TETOFF promoter on a low-copy plasmid,
this overexpression of ISU1 in the crd1Δisu1Δ double mutant reversed the
growth defect (Fig. 2.5B).
The genetic interaction between crd1Δ and isu1Δ is consistent with
perturbation of Fe-S biogenesis in crd1Δ and suggests that decreased Fe-S
biogenesis resulting from CL deficiency is exacerbated by further loss of the Fe-S
scaffold in the presence of the isu1Δ mutation.

Increased expression of ATM1 does not rescue iron defects in crd1Δ:
The inner membrane protein Atm1, which is involved in the export of Fe-S
co-factors from mitochondria, is activated by CL (Kuhnke et al., 2006): the in vitro
activity of Atm1 is ~50% lower in the absence of CL. If upregulation of the iron
regulon resulted from reduced Atm1 activity, then increasing Atm1 levels in
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Figure 2.5. Genetic interaction between crd1Δ and isu1Δ. (A) Cells were
precultured overnight in YPD, serially diluted, spotted on SD glucose or
galactose plates, and incubated at 30°C for 3-5 days. (B) Cells were precultured
overnight in SD glucose lacking tryptophan, serially diluted, spotted on SD
glucose or galactose plates lacking tryptophan, and incubated for 3-5 days.
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crd1Δ cells might be expected to restore the elevated iron regulon to WT levels.
However, overexpression of ATM1 in crd1Δ cells did not restore the expression
of FET3, FIT2, and FIT3 to WT levels (Fig. 2.6). In addition, others have shown
that loss of ATM1 does not affect the activities of aconitase and succinate
dehydrogenase (Kispal et al., 1999). Therefore, it is not likely that Fe-S defects
in the CL mutant result from Atm1 deficiency.

Increased expression of antioxidant genes does not rescue iron defects in
crd1Δ:
Published studies have shown that Fe-S clusters in proteins such as
aconitase are particularly sensitive to degradation by superoxide (MorenoCermeno et al., 2010; Vasquez-Vivar et al., 2000). In a previous study, we
showed that the loss of CL leads to decreased stability of respiratory
supercomplexes (Pfeiffer et al., 2003), which is expected to cause increased
ROS formation. Consistent with this, protein carbonylation, a sensitive marker of
intracellular ROS, was significantly increased in crd1Δ (Chen et al., 2008a).
Therefore, we addressed the possibility that the iron-associated growth defects in
crd1Δ cells may result from increased ROS. To do so, we determined the effect
on crd1Δ cells of increasing antioxidant production via overexpression of YAP1,
which regulates expression of a number of antioxidant genes required for
tolerance to oxidants (Lee et al., 1999; Wemmie et al., 1997). In response to
H2O2, Yap1 positively regulates genes that affect glutathione metabolism (GSH1,
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Figure 2.6. Overexpression of ATM1 in crd1Δ does not restore wild type
expression of iron-uptake genes. The mRNA levels of FET3, FIT2, and FIT3
were quantified by qPCR in cells grown in SD glycerol-ethanol at 30°C to the
logarithmic phase. Values are reported as fold change in expression over WT.
Expression was normalized to the mRNA levels of the internal control ACT1.
Data shown are mean ± SE (n=6).
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GLR1, ZWF1), catalase (CTT1), cytosolic thioredoxins (TRR1, TRX2),
glutathione peroxidases (GPX1, GPX2), and superoxide dismutases (SOD1,
SOD2) (Jamieson, 1998; Lee et al., 1999; Lucau-Danila et al., 2005; Sugiyama et
al., 2000). As seen in Fig. 2.7, overexpression of YAP1 in crd1Δ did not alleviate
methionine auxotrophy or growth sensitivity to iron and H2O2. Thus, there is no
evidence that the iron-related growth phenotypes in crd1Δ arise from oxidative
stress.
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Figure 2.7. Overexpression of YAP1 in crd1Δ does not alleviate the ironrelated growth phenotypes. Cells were precultured in SD media overnight,
serially diluted and spotted on SD galactose plates (A) supplemented with
FeSO4, (B) supplemented with H2O2, and (C) lacking methionine. Plates were
incubated for 5 days.
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Figure 2.8. Model: Perturbation of Fe-S biogenesis in crd1Δ. In the proposed
model, loss of CL leads to decreased Fe-S biogenesis and maturation of Fe-S
proteins, resulting in reduced activities of succinate dehydrogenase (II),
ubiquinol-cytochrome c oxidoreductase (III), and aconitase (Aco1) in the
mitochondria, as well as cytosolic Fe-S enzymes (Cyt Fe-S) sulfite reductase and
isopropylmalate isomerase. Decreased Fe-S biogenesis is sensed by Aft1, which
activates expression of the iron regulon genes, leading to increased
mitochondrial iron levels.
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DISCUSSION
In this study, we show for the first time that CL deficiency leads to altered
mitochondrial and cellular iron homeostasis, as seen in increased expression of
the iron regulon genes, elevated mitochondrial iron levels, and sensitivity to iron
supplementation and ROS inducing agents. Our findings indicate that the most
likely mechanism underlying the iron homeostasis defects is that of perturbation
of Fe-S biogenesis, as is evident from decreased activities of both mitochondrial
and cytosolic Fe-S enzymes, concomitant auxotrophies for the amino acid
products of these enzymes, and synthetic interaction of crd1Δ with the
mitochondrial Fe-S scaffolding mutant isu1Δ. The observed decrease in Fe-S
enzyme activity is not likely to result solely from a loss of direct enzyme activation
by CL in the mitochondrial inner membrane. While the mitochondrial enzymes
succinate dehydrogenase and ubiquinol-cytochrome c oxidoreductase are
membrane-bound and may be activated by CL, aconitase is a matrix enzyme that
is unlikely to be directly regulated by CL. Furthermore, we observed reduced
activity of cytosolic Fe-S enzymes sulfite reductase and isopropylmalate
isomerase, which are not in contact with the mitochondrial membrane.
How does CL deficiency cause perturbation of mitochondrial Fe-S
biogenesis? Several potential mechanisms can be ruled out. First, the Fe-S
defects are most likely not due to decreased Atm1 activity, as overexpression of
ATM1 did not rescue the iron regulon defects (Fig. 2.6). Furthermore, as previous
studies indicated that aconitase and succinate dehydrogenase activities are not
affected by decreased expression of ATM1, it is unlikely that decreased activities
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of aconitase and succinate dehydrogenase observed in the CL mutant result
from Atm1 deficiency (Kispal et al., 1999). A second potential mechanism,
disruption of Fe-S clusters by increased ROS in the CL mutant, is also unlikely,
as overexpression of YAP1 in crd1Δ did not alleviate methionine auxotrophy or
growth sensitivity to iron and H2O2 (Fig. 2.7). Furthermore, we observed elevated
expression of the iron regulon genes even in fermentative growth conditions,
during which protein carbonylation in CL mutants is not increased (Chen et al.,
2008a). In addition, expression of antioxidant genes is not increased during these
growth conditions in crd1Δ (Patil et al., 2012). Therefore, there is no evidence
that ROS contributes to the observed iron phenotypes of crd1Δ cells.
A third possibility, perturbation of glutathione (GSH) metabolism, is also
not a likely cause of Fe-S defects in the CL mutant. GSH plays a critical role in
maintaining an intracellular reducing environment and regulates cellular iron
homeostasis (Kumar et al., 2011; Sipos et al., 2002). While perturbation of GSH
metabolism does lead to elevated mitochondrial iron levels and decreased
cytosolic Fe-S biogenesis, depletion of GSH does not affect activities of the
mitochondrial Fe-S proteins succinate dehydrogenase and aconitase, which are
reduced in crd1Δ (Sipos et al., 2002). However, depletion of GSH, a tripeptide of
glutamate, cysteine, and glycine, is a predicted outcome of Fe-S deficiency. First,
the glutamate precursor α-ketoglutarate is likely to be depleted as a result of
aconitase deficiency. Second, decreased activity of the Fe-S enzyme glutamate
synthase would lead to a decrease in the conversion of glutamine and αketoglutarate to glutamate (Shakoury-Elizeh et al., 2004; Vanoni and Curti,
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1999). Third, decreased activity of sulfite reductase is expected to affect
synthesis of methionine, the sulfur donor for synthesis of cysteine. Therefore, it is
probable that glutathione deficiency is a downstream effect of Fe-S defects in
CL-deficient cells.
Previous studies have indicated that yeast cells exhibit iron deficiency
resulting from defective vacuolar protein sorting or activation of Fet3, which may
activate the iron regulon (Davis-Kaplan et al., 2004; Radisky et al., 1997).
However, defective vacuolar function is not a likely cause of upregulation of the
iron regulon in crd1Δ cells because, in the current study, mitochondria from
crd1Δ cells contain elevated, rather than decreased, levels of iron.
The most likely explanation for perturbation of Fe-S biogenesis in CL
deficient cells is that alterations in the mitochondrial membrane perturb the
stability and integrity of the protein complexes that drive mitochondrial protein
import (Kutik et al., 2008; Tamura et al., 2009). We have shown that crd1Δ cells
exhibit defective import of precursor proteins into mitochondria (Jiang et al.,
2000; Kutik et al., 2008). Cells lacking CL may be compromised in the import of a
protein or nutrient important for Fe-S biogenesis in the matrix. Recent studies
have shown that Zim17, a heat-shock protein, interacts with both Ssc1 and PAM
to promote their activities (Diaz de la Loza Mdel et al., 2011; Sanjuan Szklarz et
al., 2005). Mitochondria from the ZIM17 mutant exhibit decreased protein import
due to aggregation of Pam16, Ssc1, and Ssq1 proteins (Burri et al., 2004; Diaz
de la Loza Mdel et al., 2011; Sanjuan Szklarz et al., 2005; Yamamoto et al.,
2005). Aggregation of both Ssc1 and Ssq1 result in decreased Fe-S biogenesis,
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leading to upregulation of the Aft1-controlled iron regulon. The loss of CL may
affect mitochondrial import or processing of Fe-S biosynthetic proteins or,
alternatively, affect nutrient import through inner membrane carrier proteins.
Experiments to address this mechanism are in progress.
We propose the following model for the role of CL in maintaining
mitochondrial and cellular iron homeostasis (Fig. 2.8). CL deficiency leads to
decreased mitochondrial import of Fe-S proteins resulting in defects in Fe-S
cluster biogenesis and maturation of Fe-S proteins and thus reduced activities of
mitochondrial and cytosolic Fe-S enzymes. The cellular response to the
decrease in Fe-S biogenesis is up-regulation of the iron regulon, leading to
elevated mitochondrial iron levels.
It remains unclear how CL deficiency contributes to the observed
pathology in BTHS. Interestingly, some of the clinical symptoms found in BTHS
patients are also seen in patients with Fe-S biogenesis defects. Mutations in the
human ISCU gene, which is homologous to yeast ISU1, lead to deficiencies in
succinate

dehydrogenase

and

aconitase

in

skeletal

muscle,

causing

cardiomyopathy, lactic acidosis, muscle weakness, and exercise intolerance (Hall
et al., 1993; Haller et al., 1991; Kollberg et al., 2009; Mochel et al., 2008).
Depletion of several proteins of the Fe-S biosynthetic machinery severely affects
mitochondrial inner membrane structure and cristae morphology (Biederbick et
al., 2006; Sheftel et al., 2012), similar to what has been observed in the
lymphoblasts of BTHS patients (Acehan et al., 2007). In addition, deficiency of
frataxin, which is involved in mitochondrial Fe-S biogenesis, is characterized by

60
hypertrophic cardiomyopathy and heart failure (Durr et al., 1996). Interestingly,
overexpression of frataxin leads to increased mitochondrial membrane potential,
elevated ATP levels, resistance to oxidative stress, and life-span extension
(Ristow et al., 2000; Runko et al., 2008), defects which are characteristic of CL
deficiency (Joshi et al., 2009). In transgenic mice, overexpression of frataxin
counteracted cardiotoxic stress, preventing cardiomyopathy and cardiac failure
(Schulz et al., 2010). We suggest that mitochondrial iron homeostasis may be an
important physiological modifier that contributes to the phenotypes observed in
BTHS patients.
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CHAPTER 3
LOSS OF CARDIOLIPIN LEADS TO GLUTATHIONE DEFICIENCY

INTRODUCTION

In the studies discussed in the previous chapter, I demonstrated that CL
deficiency leads to perturbation of iron homeostasis due to decreased Fe-S
biogenesis (Patil et al., 2012). The majority of iron taken up by yeast cells is
utilized for the synthesis of Fe-S clusters, which are incorporated as co-factors
into iron-dependent enzymes (Kaplan et al., 2006). In addition to enzymes
required for mitochondrial bioenergetics, several amino acid biosynthetic
enzymes are dependent on Fe-S clusters (Lill and Muhlenhoff, 2008). In yeast,
iron-dependent enzymes involved in amino acid synthesis include aconitase
(Aco1), glutamate synthase (Glt1), sulfite reductase (Met5), dihydroxyacid
dehydratase (Ilv3), isopropylmalate isomerase (Leu1), and homoaconitase (Lys4)
(Lill and Muhlenhoff, 2008). Therefore, decreased Fe-S biogenesis is expected to
disrupt amino acid synthesis, causing severe metabolic perturbations.
As discussed in chapter two, I have shown that the crd1Δ mutant exhibits
decreased activity of aconitase (Patil et al., 2012). Aconitase catalyzes the
conversion of citrate to isocitrate, which is converted to α-ketoglutarate by
isocitrate dehydrogenase (Cupp and McAlister-Henn, 1991; Cupp and McAlisterHenn, 1992). α-ketoglutarate is an essential substrate for the synthesis of
glutamate (Chen et al., 2005; Gangloff et al., 1990). A decrease in α-
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ketoglutarate is expected to cause depletion of glutamate. Sulfite reductase,
which catalyzes the conversion of sulfite to sulfide, is essential for the synthesis
of both methionine and cysteine (Masselot and De Robichon-Szulmajster, 1975;
Masselot and Surdin-Kerjan, 1977). The crd1Δ mutant exhibits decreased activity
of sulfite reductase along with auxotrophy for methionine (Patil et al., 2012).
Depletion of these amino acids is expected to decrease the synthesis of
glutathione (GSH), an essential antioxidant. GSH is synthesized in the cytosol
from glutamate, cysteine, and glycine, through sequential reactions catalyzed by
Gsh1 (γ-glutamyl cysteine synthase) and Gsh2 (glutathione synthase) (Inoue et
al., 1998; Ohtake and Yabuuchi, 1991) (Fig. 3.1). The synthesis of GSH is under
the regulatory control of the transcription factor Yap1 (Lee et al., 1999; Sugiyama
et al., 2000; Wu and Moye-Rowley, 1994). Activation of Yap1 by oxidative stress
and temperature shock, or by overexpression of the YAP1 gene augments the
expression of GSH1 and GSH2 and elevates GSH levels (Sugiyama et al., 2000;
Wu and Moye-Rowley, 1994).
GSH is the major free thiol that functions to maintain a reducing
environment and to combat oxidative stress (Kumar et al., 2011; Meister, 1988;
Penninckx, 2002). GSH acts as a co-factor for antioxidant enzymes such as
glutathione peroxidase, which utilize GSH to neutralize the reactive oxygen
species (ROS) (Jamieson, 1998). The antioxidant function of GSH depends on
the active thiol group (-SH) (Jamieson, 1998). GSH donates electrons necessary
to reduce the ROS, and in turn, is oxidized to glutathione disulfide (GSSG). To
regenerate GSH, glutathione reductase (Glr1) catalyzes the reduction of GSSG,
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Figure 3.1. The GSH biosynthetic pathway and the redox cycle in yeast.
Enzymes are indicated in red, and intermediate steps are shown in blue.
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and NADPH for this reaction is provided by glucose 6-phosphate dehydrogenase
(Zwf1) (Grant, 2001; Izawa et al., 1998; Nogae and Johnston, 1990; Outten and
Culotta, 2004; Outten et al., 2005) (Fig. 3.1). The depletion of GSH leads to
increased sensitivity to oxidants such as hydrogen peroxide (H2O2), while
elimination of GSH synthesis by the deletion of GSH1 leads to growth arrest
(Jamieson, 1998). Therefore, to maintain vital cellular functions, intracellular GSH
levels must be rigorously maintained by de novo synthesis, redox cycling, or
uptake from the growth media.
Because activities of Fe-S enzymes involved in the synthesis of glutamate
and cysteine are decreased, I hypothesized that growth defects observed in
crd1Δ cells are due to depletion of glutamate and cysteine, which leads to GSH
deficiency. Consistent with this prediction, growth of crd1Δ at elevated
temperature is restored by supplementation of both glutamate and cysteine or
GSH. The data presented in this study show for the first time that CL is required
for the synthesis of GSH.
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MATERIALS AND METHODS

Yeast strains and growth media
The yeast strains used in this study are listed in Table 1. Synthetic defined
(SD) medium contained adenine (20.25 mg/l), arginine (20 mg/l), histidine (20
mg/l), leucine (60 mg/l), lysine (20 mg/l), methionine (20 mg/l), threonine (300
mg/l), tryptophan (20 mg/l), and uracil (20 mg/l), yeast nitrogen base without
amino acids (Difco, Detroit, MI), and carbon source (fermentative) glucose (2%)
or (respiratory) glycerol (3%) plus ethanol (1%) or (respiro-fermentative)
galactose (2%). SD drop out medium contained all of the above-mentioned
ingredients except for the indicated amino acid. For testing iron sensitivity, the
growth media was supplemented with 1 µM CuSO4 and FeSO4 was solubilized in
0.1 N HCl, filter-sterilized and added to the culture medium at the indicated
concentration. GSH stock (250 mM) was prepared in distilled water, filtersterilized and diluted to achieve the desired final concentration.

Construction of double mutants
The CL mutant strain crd1Δ::URA3 MATα was crossed with mutants of the
opposite mating type obtained from the yeast deletion collection (Invitrogen).
Heterozygous diploids were selected on SD dropout media lacking methionine
and lysine, sporulated, and tetrads were dissected. Synthetic interactions
between CL and deletion mutants was determined by comparing growth of the
double mutant to isogenic parent and wild type strains on YPD.
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Table 3.1. Yeast strains and plasmids used in this study.

Strain
FGY3
FGY2
BY4742
BY4742
VGY1
gsh1Δ
glr1Δ
zwf1Δ
VGY1
gsh1Δ
VGY1
glr1Δ
VGY1
zwf1Δ
YEp351
YEp351YAP1

Genotype
MATa, ura3-52, lys2-801, ade2-101, trp1-Δ1,
his3-Δ200, leu2-Δ1
MATa, ura 3-52, lys2-801, ade2-101, trp1-Δ1,
his3-Δ200, leu2-Δ1, crd1Δ::URA3
MAT
leu 200,
200, lys
lys 200,
200, ura
ura 300
300
MATα
α,, his
his 301,
301, leu
MATα, his 301, leu 200, lys 200, ura 300,
crd1Δ::URA3
MATa, his 301, leu 200, met 1500, ura 300,
gsh1Δ::KanMX4
MATa, his 301, leu 200, met 1500, ura 300,
glr1Δ::KanMX4
MATa, his 301, leu 200, met 1500, ura 300,
zwf1Δ::KanMX4
MATa, his 301, leu 200, met 1500, ura 300,
gsh1Δ::KanMX4, crd1Δ::URA3
MATa, his 301, leu 200, met 1500, ura 300,
glr1Δ::KanMX4, crd1Δ::URA3
MATα, his 301, leu 200, lys 200, ura 300,
zwf1Δ::KanMX4, crd1Δ::URA3
High-copy number plasmid, LEU2 nutritional
marker
Derivative of YEp351, expresses YAP1 from the
native promoter

Reference
(Jiang et al., 1997)
(Jiang et al., 1997)
Invitrogen
Invitrogen
(Gohil et al., 2005)
Invitrogen
Invitrogen
Invitrogen
This study
This study
This study
(Hill et al., 1986)
(Wemmie et al.,
1994)
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Mitochondria isolation
Mitochondria were isolated from cell lysates prepared as previously
described (Diekert et al., 2001). Briefly, spheroplasts obtained by zymolase
treatment were disrupted by Dounce homogenization, and mitochondria were
isolated by differential centrifugation. Total protein concentration was determined
with a Bradford assay kit (BioRad), with BSA as the standard.

SDS-PAGE and western blot analyses of mitochondrial Fe-S assembly
proteins
Mitochondria isolated from cells grown to an A550 of 1.0 were lysed in
sample buffer (250 mM Tris pH 6.8, 2% SDS, 10% glycerol, 0.01% bromophenol
blue, and 20% β-mercaptoethanol) by heating the lysate to 95°C for 5 mins. The
lysate was subjected to SDS-PAGE and transferred to polyvinylidene difluoride
membrane as described in Zhong et al. (2007). The blots were probed with
polyclonal primary antibodies (rabbit) against Yfh1 and Nfs1 (gifts from Dr.
Andrew Dancis), and Isu and porin (gifts from Dr. Roland Lill). Anti-rabbit IgG
horseradish peroxidase-conjugated secondary antibodies (Promega) were
visualized with ECL Prime chemiluminescence detecting reagents.
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RESULTS

Growth of crd1Δ at elevated temperature is restored by supplementation
with GSH or with glutamate and cysteine:
The data presented in the previous chapter showed that the loss of CL
leads to decreased activities of Fe-S enzymes aconitase and sulfite reductase
(Patil et al., 2012). Because these enzymes are essential for the synthesis of
glutamate and the sulfur-containing amino acids (methionine or cysteine),
respectively, I hypothesized that the growth defect in crd1Δ at elevated
temperature may be due to depletion of both glutamate and cysteine. Consistent
with this prediction, the growth of crd1Δ at elevated temperature is restored by
supplementation of glutamate and cysteine (Fig. 3.2). Supplementation of
cysteine alone partially rescued the growth defect in crd1Δ, but glutamate alone
did not (Fig. 3.3). This suggests that cysteine, and to a lesser extent, glutamate
levels are decreased in the crd1Δ mutant.
Both glutamate and cysteine are essential precursors for the synthesis of
GSH. Because crd1Δ cells are auxotrophic for glutamate and cysteine, I further
predicted that the growth defect in crd1Δ at elevated temperature is due to GSH
deficiency. Consistent with this prediction, the growth defect of crd1Δ was
rescued by GSH supplementation (Fig. 3.4). These results indicate that GSH
deficiency in the CL mutant is due to the depletion of both glutamate and
cysteine.
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Figure 3.2. Supplementation of glutamate and cysteine restored the growth
of crd1Δ at elevated temperature. Cells were precultured in SD galactose
overnight, serially diluted, and spotted on SD galactose plates containing the
indicated amounts of glutamate and cysteine, and incubated at 37°C for 4 days.
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A

B

Figure 3.3. Supplementation of cysteine partially rescued the growth of
crd1Δ at elevated temperature. Cells were precultured in SD galactose
overnight, serially diluted, and spotted on SD galactose plates containing the
indicated amounts of (A) glutamate or (B) cysteine, and incubated at 37°C for 4
days.
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Figure 3.4. GSH supplementation restored the growth of crd1Δ at elevated
temperature. Cells were precultured in SD galactose overnight, serially diluted,
spotted on SD galactose plates containing the indicated amounts of GSH, and
incubated at 37°C for 4 days.

72
Overexpression of YAP1 did not rescue growth of crd1Δ at elevated
temperature:
GSH is synthesized from glutamate, cysteine, and glycine, through
sequential reactions catalyzed by Gsh1 and Gsh2 (Inoue et al., 1998; Ohtake
and Yabuuchi, 1991). Expression of both GSH1 and GSH2 is regulated by the
transcription factor Yap1 (Sugiyama et al., 2000). Consistent with this,
overexpression of YAP1 activates the transcription of GSH1 and GSH2, thereby
increasing GSH levels (Sugiyama et al., 2000). To address the possibility that
GSH deficiency results from decreased GSH biosynthetic enzymes, YAP1 was
overexpressed

in

crd1Δ

cells.

In

contrast

to

GSH

supplementation,

overexpression of YAP1 did not rescue the growth of crd1Δ at elevated
temperature (Fig. 3.5). This suggests that GSH deficiency in crd1Δ does not
result from deficient enzymes for the synthesis of GSH.

GSH supplementation alleviates growth sensitivity of crd1Δ to oxidants:
Previous studies have shown that the loss of CL leads to increased
oxidative stress, and that the crd1Δ mutant is sensitive to growth in the presence
of iron and H2O2 (Chen et al., 2008a; Patil et al., 2012). In yeast cells, GSH is the
most abundant antioxidant molecule that is essential to maintain resistance to
oxidants (Jamieson, 1998). Consistent with this, GSH deficient mutants are
hypersensitive to H2O2 (Jamieson, 1998). To address the possibility that GSH
deficiency in crd1Δ may account for growth sensitivity of the mutant to iron and
H2O2, crd1Δ cells were grown in the presence of 7 mM FeSO4 or 350 mM H2O2,
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Figure 3.5. Overexpression of YAP1 did not alleviate the growth defect of
crd1Δ at elevated temperature. Cells were precultured in SD galactose
overnight, serially diluted, spotted on SD galactose plates lacking leucine, and
incubated for 4-5 days.
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in the presence or absence of 1 mM GSH. GSH supplementation significantly
improved the growth of crd1Δ in the presence of iron or H2O2 (Fig. 3.6). This
suggests that the growth sensitivity of crd1Δ to oxidants is due to GSH
deficiency.

Genetic interaction between CRD1 and GSH metabolic pathway genes:
If the loss of CL leads to GSH deficiency, which accounts for the
increased ROS, then further perturbation of GSH synthesis could be expected to
exacerbate the growth defect of crd1Δ. Consistent with this prediction, deletion of
GSH1 in crd1Δ cells leads to synthetic lethality (Fig. 3.7). The genetic interaction
between CRD1 and GSH1 is consistent with increased oxidative stress in crd1Δ,
which is further exacerbated by the deletion of GSH1.
To preserve a reducing environment, GSH must be maintained in the
reduced form, by converting GSSG to GSH. For redox cycling of GSSG to GSH,
both glutathione reductase (Glr1) and glucose 6-phosphate dehydrogenase
(Zwf1), which provides NADPH for the reaction are required (Grant, 2001; Izawa
et al., 1998; Nogae and Johnston, 1990; Outten and Culotta, 2004; Outten et al.,
2005). Deletion of either GLR1 or ZWF1 is expected to disrupt regeneration of
GSH and exacerbate the growth of crd1Δ. Consistent with this prediction,
deletion of GLR1 or ZWF1 in crd1Δ cells leads to synthetic sick interactions in
galactose-containing media at 39°C. (Fig. 3.8). The synthetic interaction of crd1Δ
with zwf1Δ is stronger than with glr1Δ, which suggests that, in addition to
alterations in GSH, cytosolic NADPH levels may be decreased in crd1Δ. The
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Figure 3.6. GSH supplementation alleviated growth sensitivity of crd1Δ to
H2O2 and FeSO4. Cells were precultured in YPD overnight, serially diluted, and
spotted on SD galactose plates containing (A) 0.35 mM H2O2 or (B) 7 mM
FeSO4, supplemented with 1 mM GSH as indicated, and incubated at 30°C for 5
days.
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Figure 3.7. Genetic interaction between crd1Δ and gsh1Δ. Cells were
precultured in YPD overnight, serially diluted, spotted on YPD and SD glucose,
and incubated at 30°C.
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Figure 3.8. Genetic interaction between crd1Δ, zwf1Δ, and glr1Δ. Cells were
precultured in YPD overnight, serially diluted, spotted on SD galactose plates,
and incubated at 30°C and 39°C.
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synthetic genetic interactions of gsh1Δ, zwf1Δ, and glr1Δ with crd1Δ indicate that
perturbation of GSH metabolism in the CL mutant further contributes to the
oxidative stress, which exacerbates the growth defect.

Loss of CL leads to decreased Yfh1 levels:
The most likely explanation for GSH deficiency in crd1Δ cells is decreased
maturation of Fe-S proteins aconitase and sulfite reductase, which are essential
for the synthesis of glutamate and cysteine (Gerber et al., 2004; Kispal et al.,
1999; Lange et al., 2000; Muhlenhoff et al., 2002). To test the possibility that the
protein(s) required for mitochondrial Fe-S cluster assembly are decreased in
crd1Δ, I carried out a Western blot analysis of the steady-state levels of three
core components involved in mitochondrial Fe-S assembly, Yfh1, Nfs1, and Isu.
As seen in Fig. 3.9, Yfh1, the putative iron donor for mitochondrial Fe-S
assembly, is decreased in crd1Δ. However, Nfs1 and Isu levels are unaltered in
the mutant. This suggests that the expression, import or stability of Yfh1 is
decreased in crd1Δ, which may account for defective mitochondrial Fe-S
biogenesis and GSH deficiency.
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Figure 3.9. Decreased Yfh1 in crd1Δ. Western blot analysis of Nfs1, Yfh1, and
Isu proteins from mitochondrial extracts of cells grown in SD galactose at 35°C.
Por1 was used as a loading-control.
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Figure 3.10. Proposed model for GSH deficiency in crd1Δ. Loss of CL leads
decreased Yfh1 protein, causing perturbation of mitochondrial Fe-S biogenesis.
Defective Fe-S biogenesis leads to elevated mitochondrial iron levels and
decreased maturation of aconitase (Aco1) and sulfite reductase (SiR), which
results in reduced synthesis of glutamate and cysteine, precursors required for
GSH synthesis. Decreased GSH levels and elevated mitochondrial iron
contribute to an increase in ROS, which inhibits the growth of crd1Δ.
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DISCUSSION

In this study, we provide evidence that perturbation of CL synthesis leads
to GSH deficiency: 1) growth of crd1Δ at elevated temperature is restored by
supplementation of GSH and GSH precursors; 2) GSH supplementation restored
the growth of crd1Δ in the presence of oxidants; 3) deletion of genes for GSH
synthesis are synthetically lethal with crd1Δ; and 4) Yfh1 levels are decreased,
suggesting that mitochondrial Fe-S cluster assembly is reduced in crd1Δ.
Collectively, these findings indicate that GSH deficiency in crd1Δ is due to the
depletion of precursors for GSH synthesis, which is caused by defective Fe-S
biogenesis.
The finding that GSH supplementation alleviated the growth defect of
crd1Δ at elevated temperature suggests that GSH levels in crd1Δ are decreased.
To maintain high intracellular GSH concentrations, yeast cells can take up GSH
from the growth media or synthesize it through the de novo pathway. In synthetic
dropout media, which is devoid of specific amino acids and GSH, yeast cells
depend entirely on intracellular GSH synthesis from glutamate, cysteine, and
glycine. Auxotrophies for glutamate and cysteine suggest that synthesis of both
amino acids are decreased in crd1Δ (Fig. 3.2), which is further supported by the
finding that overexpression of YAP1 did not restore the growth of crd1Δ at
elevated temperature (Fig. 3.5) or improve resistance of crd1Δ to iron and H2O2
(Patil et al., 2012).
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GSH supplementation restored the growth of crd1Δ in presence of both
iron and H2O2 (Fig. 3.6), which suggests that, compared to WT cells, the CL
mutant is unable to increase GSH synthesis to efficiently neutralize the ROS.
This is supported by findings that mutations in genes for GSH synthesis and
redox cycling lead to synthetic interactions with crd1Δ, which indicates that
oxidative stress in the crd1Δ mutant is further exacerbated by perturbations in
GSH synthesis (Figs. 3.7 and 3.8).
A decrease in Yfh1 protein in crd1Δ suggests that the transport of iron to
the Isu scaffold may be defective, which is consistent with decreased activity of
Fe-S enzymes and perturbation of mitochondrial Fe-S biogenesis (Patil et al.,
2012). Several possibilities may account for decreased Yfh1 protein in crd1Δ.
Previous studies have shown that perturbation of CL synthesis leads to
decreased mitochondrial protein import (Gebert et al., 2009; Jiang et al., 2000).
Consistent with this, the import of Yfh1 in CL-deficient mitochondria may be
decreased. Alternatively, the stability of the protein may be decreased, leading to
increased protein turnover. Yfh1 is localized in close proximity to the CL-enriched
mitochondrial inner membrane (Campuzano et al., 1997). Interaction of Yfh1 with
CL and/or inner membrane protein subunits of succinate dehydrogenase may be
required for Yfh1 function (Gonzalez-Cabo et al., 2005).
Based on the data obtained, I propose the following model to depict the
role of CL in regulating GSH homeostasis (Fig. 3.10). Perturbation of CL
synthesis leads to decreased Yfh1 protein, which disrupts mitochondrial Fe-S
biogenesis. Defective Fe-S biogenesis leads to elevated mitochondrial iron levels
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and decreased maturation of aconitase and sulfite reductase, which results in
reduced synthesis of glutamate and cysteine, precursors required for GSH
synthesis. Decreased GSH synthesis and elevated mitochondrial iron contribute
to the ROS generated, which inhibits the growth of crd1Δ.
The data presented here suggest that CL is a critical regulator of amino
acid synthesis and GSH homeostasis. These findings could be potentially used
to develop treatments for Barth syndrome (BTHS) patients, as early reports
indicate that BTHS patients exhibit metabolic deficiencies similar to those
identified in CL-deficient yeast cells (Dr. Richard Kelley, Kennedy Krieger
Institute, John Hopkins). Mass spectrometric analyses of the plasma from BTHS
patients indicate that the TCA cycle intermediate cis-aconitate is elevated. Cisaconitate is an intermediate formed during the conversion of citrate to isocitrate
(Krebs and Holzach, 1952). Elevated cis-aconitate levels suggest that the
enzymatic activity of aconitase may be decreased. BTHS patients also exhibit
significant health improvement when orally supplemented with methionine,
cysteine, or GSH (personal communication, Dr. Richard Kelley), which would be
consistent with depletion of sulfur-amino acids in BTHS patients. In summary, the
findings reported in this study and the preliminary data obtained from the studies
of BTHS patients indicate that GSH could be an important physiological modifier
of CL deficiency in BTHS.
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CHAPTER 4

SUPPRESSORS OF CRD1Δ GROWTH DEFICIENCY AT ELEVATED
TEMPERATURE

INTRODUCTION

The primary hurdle for the effective treatment of BTHS is that the
mechanisms linking the pathology and CL deficiency are not known. In addition,
the clinical phenotypes of BTHS vary widely, even among patients with the
identical mutation, suggesting that genetic and physiological factors exacerbate
the consequences of perturbation of CL synthesis. Therefore, there is an
imminent need to determine cellular functions of CL.
To obtain an understanding of CL functions that might explain the cellular
defects in BTHS, a screen was carried out to identify genes that, when
overexpressed, compensate for the loss of CL. A previous screen for
suppressors of growth defects of the pgs1Δ mutant led to the identification of an
unexpected role of PG and/or CL in regulating cell wall biogenesis (Zhong and
Greenberg, 2005). A loss-of-function mutation in the gene KRE5 restored the
growth of pgs1Δ by strengthening the cell wall, demonstrating that PG and/or CL
mediate cross-talk between the mitochondria and the cell wall. The current study
was carried out to identify suppressors of crd1Δ. The crd1Δ mutant is unable to
form colonies at elevated temperature from single cells on media containing the
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fermentable carbon source, glucose (Jiang et al., 1999; Jiang et al., 2000; Zhong
et al., 2004). Interestingly, studies described in chapters two and three indicate
that CL-deficient cells exhibit perturbation of mitochondrial Fe-S biogenesis, iron
homeostasis, GSH deficiency and growth sensitivity to iron and H2O2 in
galactose-containing media. Although galactose, like glucose, is a fermentable
carbon source, ATP synthesis by fermentation alone is not sufficient in
galactose-containing media. First, galactose has to be converted to glucose 6phosphate by the Leloir pathway enzymes, which comprise ~5% of total cellular
proteins (Bhat, 2008). Second, 2 ATP/galactose molecule consumed is
inadequate to synthesize galactolytic enzymes and support growth at the same
time. Therefore, pyruvate generated by fermentation is simultaneously oxidized
via the TCA cycle and respiration. In contrast, in glucose-containing media, yeast
cells almost entirely use fermentation to generate ATP, and switch to the
respiratory mode after glucose is converted to ethanol (Lagunas, 1986). The
difference in utilization of these two carbon sources is evident from the doubling
time of rho° cells (cells lacking mitochondrial DNA), which is ~70 minutes in
glucose and ~140 minutes in galactose (Bhat, 2008). Therefore, to increase
stringency of the screen, I identified suppressors of the growth defect on
galactose.
The suppressor screen utilizing a high copy genomic DNA library led to
the identification of fifty putative suppressors of crd1Δ. Five plasmids were intially
sequenced, and interestingly, each plasmid contained the same region of
chromosome III, spaning four genes. One of the genes was LEU2, which is
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involved in leucine biosynthesis, a process that is perturbed in the crd1Δ mutant
(chapter two). This supports the finding that perturbation of leucine synthesis
likely contributes to the growth defect of crd1Δ.
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MATERIALS AND METHODS
Strains and growth media
The yeast strains used in this work are listed in Table 1. The ingredients of
synthetic defined (SD) growth media are as described in the previous chapter.
SD glucose and SD galactose contain synthetic defined growth media lacking
leucine, and either glucose (2%) or galactose (2%).
Escherichia coli (E. coli) cells were grown in Luria Bertani (LB) media,
which is composed of Bacto-tryptone (10 gm/l), yeast extract (5 gm/l), and NaCl
(10 gm/l). E. coli transformants were selected in LB media containing ampicillin
(100 µg/ml).

Transformation and isolation of plasmids
Transformation of plasmids in E. coli and yeast were done by
electroporation (Delorme, 1989; Woodall, 2003). Plasmids from E. coli were
isolated using Wizard® Plus SV Minipreps (Promega), whereas plasmids from
yeast cells were extracted using the Zymoprep™ Yeast Plasmid Miniprep II kit
(Zymo Research).
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Table 4.1. Yeast and E. coli strains, and plasmids used in this study.

Strain

Genotype

FGY3
FGY2
YEp351
YEp351-genomic
DNA library
DH5α

MATa, ura3-52, lys2-801, ade2-101, trp1-Δ1,
his3-Δ200, leu2-Δ1
MATa, ura 3-52, lys2-801, ade2-101, trp1-Δ1,
his3-Δ200, leu2-Δ1, crd1Δ::URA3
High-copy number plasmid, LEU2 nutritional
marker
Derivative of YEp351, 7-10 kb fragments of
yeast genomic DNA, expression driven by the
native promoter
fhuA2, lacUΔ169, phoA, glnV44, Φ80'
lacZΔM15, gyrA96, recA1, relA1, endA1, thi-1,
hsdR17

Table 4.2. Primers used for sequencing.
Gene
M13 F24
M13 R22

Primer
Forward
Reverse

Sequence
CGCCAGGGTTTTCCCAGTCACGAC
TCACACAGGAAACAGCTATGAC

Source or
reference
(Jiang et al.,
1997)
(Jiang et al.,
1997)
(Hill et al., 1986)
(Wemmie et al.,
1994)
(Taylor et al.,
1993)
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RESULTS
Transformation of the cDNA library and suppressor screening:
The crd1Δ mutant exhibits growth deficiency in galactose-containing
media, but not in glucose, at elevated temperature (37° - 38°C) (Fig. 4.1). To
identify genes that alleviate the growth deficiency of crd1Δ at elevated
temperature, crd1Δ cells were transformed with a yeast genomic DNA library
(Delorme, 1989). This library consists of 7-10 kb partially digested genomic DNA
fragments inserted into SalI digested YEp351 (5.644 kb) plasmid. Transformants
were selected on SD glucose Leu- plates and replicated on SD galactose Leuplates. Plates were incubated at 30° and 38°C for 3-4 days. The colonies that
grew at 38°C compared to colonies transformed with empty vector were selected.
To eliminate false-positives, suppressors were streaked on fresh SD galactose
Leu- plates and incubated at 38°C for 3 days (Fig. 4.2). The colonies that grew at
38°C were re-streaked on fresh SD galactose Leu- plates and incubated at 38°C
for the final selection (Fig. 4.3). The growth of suppressors at each step was
compared with the growth of crd1Δ cells containing the empty plasmid (negative
control) and WT cells containing the empty plasmid (positive control). In this
manner, 15,000 transformants were screened and 50 putative suppressors of
crd1Δ growth deficiency were obtained.

Identification of suppressors of crd1Δ growth deficiency:
To isolate the plasmids, the suppressors were streaked on fresh SD
glucose Leu- plates, and cells from a single colony were inoculated into SD
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Figure 4.1. Growth deficiency of crd1Δ in galactose at elevated
temperature. Cells were precultured in YPD overnight, serially diluted, spotted
on SD plates containing glucose or galactose, and incubated at 30°C or 37°C.
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Figure 4.2. Suppressors of crd1Δ growth deficiency. Suppressors were restreaked on SD galactose plates lacking leucine and incubated at 38°C for 3
days. Arrows indicate WT and crd1Δ cells containing the empty plasmid, while
suppressors are circled.
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Figure 4.3. Confirmation of suppressors of crd1Δ growth deficiency. To
eliminate false-positives, suppressors (shown in Fig. 4.2) were re-streaked on
fresh SD galactose plates lacking leucine and incubated at 38°C for 3 days.
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glucose Leu- liquid media and incubated overnight. Because the plasmid yield
from yeast was too low for sequencing analysis, plasmids from yeast were
transformed into E. coli cells, and transformants were selected on LB plates
containing ampicillin. As a pilot experiment, five plasmids were submitted to the
AGTC sequencing facility (WSU Medical School) along with the sequencing
primers that were specifically designed to amplify the inserted genomic DNA
fragment (Table 2).
The obtained sequence information was submitted to the Saccharomyces
Genome Database (SGD) BLAST (Basic Local Alignment Search Tool) (Fig. 4.4).
Unfortunately, the sequence information obtained from the forward primer (M13
F24) did not match any region in the yeast genomic DNA. Therefore, Table 3
sequence data are based only on the M13 region amplified by the reverse primer
(M13 R22). Interestingly, each of the five plasmids contain the same region of
chromosome III, which comprise the suppressor genes listed in Table 3.
A surprising finding is that LEU2 may be a suppressor. The genetic
background of the crd1Δ strain in the current study includes the leu2-Δ1
mutation; thus, the LEU2 gene on the plasmid was used as the selectable marker
for growth at 30°C. However, the plasmid alone did not rescue the growth of the
mutant at elevated temperature. Therefore, overexpression of LEU2 may
compensate for the decrease in leucine biosynthesis that characterizes the crd1Δ
mutant, as shown in chapter two.
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Figure 4.4. Genomic DNA region identified by the reverse sequencing
primers. The dotted vertical lines show the region amplified by the sequencing
primer, while the green arrow shows the direction of amplification. The genes
present on the ‘Watson’ strand are indicated in red, while the genes present on
the ‘Crick’ strand are indicated in blue.
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Table 4.3. Putative suppressor genes of crd1Δ growth deficiency.

Gene

Strand

LEU2

Watson

YCL019W

Watson

YCL020W

Watson

YCL021W-A

Watson

Location
on
Gene function*
Chromosome III
β-isopropylmalate dehydrogenase,
91324 è 92418
catalyzes the third step of the
leucine biosynthetic pathway
Retrotransposon TYA Gag and
85102 è 90415
TYB Pol genes
Retrotransposon TYA Gag gene
85102 è 86418
co-transcribed with TYB Pol.
Putative protein of unknown
83620 è 83997
function

* Source: Saccharomyces Genome Database (www.yeastgenome.org)
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DISCUSSION

This study was carried out to identify genes that suppress the growth
defect of crd1Δ in galactose-containing media at elevated temperature. In the five
sequenced suppressors, sequences containing LEU2 restored growth of crd1Δ at
elevated temperature.
LEU2 encodes the enzyme β-isopropylmalate dehydrogenase, which
catalyzes the third step of leucine biosynthesis (Andreadis et al., 1984; Kohlhaw,
1988). The data suggest that overexpression of LEU2 rescues the growth defect
of crd1Δ, although the control plasmid, which contains the LEU2 gene as a
marker, does not. There may be several possible explanations for this finding.
Overexpression of LEU2 may cause a two-fold increase in leucine over the
control plasmid, which contains one copy of LEU2. To confirm this finding, LEU2
should be overexpressed in a plasmid containing a different nutritional marker.
Alternatively, other genes adjacent to LEU2 may suppress the growth defect in
crd1Δ (Table 3). These genes are YCL021W-A, an uncharacterized open reading
frame (ORF), and YCL019W and YCL020W, which encode the retrotransposon
TYA Gag and TYB Pol genes, respectively. TYA Gag and TYB Pol genes are
transcribed and translated as one polyprotein, which is processed to generate
nucleocapsid-like protein (Gag), reverse transcriptase (RT), protease (PR), and
integrase (IN), analogous to retroviral genes. This process may increase chances
of insertion of Ty elements (transposon-yeast) into the genome disrupting a
gene, which encodes a protein that is deleterious to crd1Δ.

97
Interestingly, LEU2 was isolated as a suppressor that restored the growth
of YFH1 point mutants (yfh1-) in respiratory conditions (Bedekovics et al., 2011).
The data in this study showed that disruption of leucine synthesis by deletion of
LEU1 or LEU2 downregulated the transcription of ACO1, which exacerbated the
phenotype of the yfh1- strain in respiratory conditions. The strains used in the
studies described in chapters two and three are leu2Δ. Therefore, an alternative
explanation for LEU2 as a suppressor of crd1Δ could be that leu2Δ may
exacerbate the phenotype of crd1Δ at elevated temperature, whereas
overexpression of LEU2 may restore the growth of crd1Δ by increasing ACO1
transcription.
Finally, leucine may be catabolized to replenish acetyl-CoA levels (Gibson
et al., 1993; Vorapreeda et al., 2012). Recent findings in the lab suggest that
generation of acetyl Co-A through the β-oxidation pathway in the peroxisomes
may be defective in crd1Δ. Therefore, the growth deficiency of crd1Δ at elevated
temperature may be due to the depletion of acetyl-CoA. A two-fold increase in
leucine by overexpressing two-copies of LEU2 may augment acetyl-CoA levels in
crd1Δ, thereby restoring growth at elevated temperature. In addition to these
possibilities, sequencing the remaining suppressors may potentially provide
insight into other cellular functions that are defective in crd1Δ.
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CHAPTER 5

FUTURE DIRECTIONS
The data presented in chapters two and three indicate that the loss of CL
leads to perturbation of mitochondrial Fe-S cluster biogenesis, which most likely
causes GSH deficiency in the CL mutant. However, the underlying mechanism
for defective Fe-S cluster biogenesis and GSH deficiency in crd1Δ cells is not
understood. In the process of Fe-S biogenesis in mitochondria, iron (Fe) and
sulfide (S) atoms are covalently linked to form Fe-S clusters, which are
transferred onto recipient proteins. Key details of this process are shown in Fig.
5.1. An exciting question for future studies is how CL plays a role in this process.

1.

What is the role of CL in mitochondrial Fe-S cluster biogenesis?
The data presented in chapter two show that the loss of CL leads to

defective mitochondrial Fe-S cluster biogenesis, which results in perturbation of
mitochondrial and cytosolic iron homeostasis. As an indication of defective Fe-S
cluster biogenesis, the activities of mitochondrial and cytosolic Fe-S enzymes are
decreased in crd1Δ (Table 2.3). However, it is unclear how CL in the inner
membrane is involved in mitochondrial Fe-S cluster biogenesis, which is largely
carried out in the matrix. Most importantly, which step(s) of Fe-S cluster
synthesis are perturbed in the absence of CL? Is the assembly of Fe-S clusters
on the Isu-scaffold or the transfer of Fe-S clusters from the Isu-scaffold to
apoproteins decreased in crd1Δ? Perturbation of either of the two steps in crd1Δ
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Fig. 5.1. Mitochondrial Fe-S cluster biogenesis in yeast. Step 1: The
assembly of Fe-S clusters in mitochondria begins on the Isu1 scaffold. Cysteine
desulfurase complex (Nfs1-Isd11) catalyzes the removal of sulfur (S) from
cysteine for delivery to Isu1. Iron (Fe) is delivered by the putative iron chaperone
protein, frataxin (Yfh1). The source of electrons for the Fe-S assembly is most
likely NADH, which is transferred by ferredoxin reductase (Arh1) and ferredoxin
(Yah1). Step 2: The 2Fe-2S clusters assembled on Isu1 are transferred to the
recipient apoproteins by interaction between Isu1 and Hsp70 chaperone Ssq1, a
process that is assisted by Jac1, Mge1, and Grx5 proteins.
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may suggest a direct role of CL in Fe-S cluster biogenesis.

2.

Why are Yfh1 levels decreased in crd1Δ?
The experiment depicted in Fig. 3.9 indicates that steady-state levels of

Yfh1 are decreased in crd1Δ, although Nfs1 and Isu proteins are not altered.
What is the cause of decreased Yfh1 in crd1Δ? At least three possibilities may
explain this decrease. First, CL is required for optimal protein import, as CL
deficient cells exhibit decreased import of precursor proteins into mitochondria
(Jiang et al., 2000; Kutik et al., 2008). Therefore, mitochondrial import of Yfh1
may be decreased in crd1Δ. Protein import assays would address this possibility.
Alternatively, the mRNA levels of YFH1 in crd1Δ may be decreased. Finally, the
stability of Yfh1 in CL-deficient mitochondria should be examined. Any of these
mechanisms may explain decreased Yfh1 in crd1Δ cells.

3.

CL and glutathione deficiency:
The data presented in chapter three show that the growth defect of crd1Δ

at elevated temperature and in the presence of oxidants (iron and hydrogen
peroxide) is rescued by GSH supplementation. This suggests that crd1Δ cells are
deficient in GSH. I suggest the following experiments to gain insight into the
mechanism of GSH deficiency in crd1Δ cells:
I.

Amino acid deficiencies in crd1Δ. The data presented in chapter

two suggest that glutamate and cysteine are depleted in crd1Δ cells. I have
shown that crd1Δ exhibits decreased aconitase activity (Table 2.3), which is

101
expected to cause depletion of α-ketoglutarate, a precursor required for the
synthesis of glutamate. Similarly, decreased activity of sulfite reductase (Table
2.3) is expected to cause depletion of cysteine. These findings are supported by
the observation that crd1Δ cells are auxotrophic for both glutamate and cysteine
(Fig. 3.2). Because glutamate and cysteine are required for GSH synthesis, I
hypothesize that GSH deficiency in crd1Δ is due to depletion of both amino
acids. Amino acids analysis to quantify glutamate and cysteine levels in cell
extracts from crd1Δ should be performed.
II.

How does GSH supplementation restore the growth of crd1Δ

at elevated temperature? I suggest two possibilities. First, the synthesis of GSH
may be decreased, as mentioned above. Alternatively, ROS produced in crd1Δ
cells may exceed the cellular capacity to respond by synthesizing and
regenerating GSH. This would be consistent with previous studies showing that
crd1Δ exhibits elevated mitochondrial iron levels and increased ROS production
(Chen et al., 2008a; Patil et al., 2012). Therefore, quantification of mitochondrial
and cytosolic GSH should be carried out to determine if GSH levels or the
GSH:GSSG ratio is decreased in crd1Δ. A decrease in GSH levels would
suggest that GSH synthesis is perturbed, whereas a decrease in the GSH:GSSG
ratio would be consistent with increased oxidative stress due to elevated ROS
production.
III.

Are

activities

of

Fe-S

enzymes

restored

by

GSH

supplementation? Previous reports have shown that Fe-S clusters in proteins
such as aconitase and isopropylmalate isomerase are particularly sensitive to
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degradation by ROS (Kispal et al., 1997; Kispal et al., 1999; Moreno-Cermeno et
al., 2010; Vasquez-Vivar et al., 2000). Therefore, if ROS accounts for decreased
activities of Fe-S enzymes, then GSH supplementation may restore the activities
of aconitase and isopropylmalate isomerase to WT levels.
4.

Suppressors of crd1Δ growth deficiency at elevated temperature:
In the suppressor screen described in chapter four, fifty putative

suppressors of crd1Δ were obtained. From five sequenced suppressor plasmids,
LEU2, which encodes the β-isopropylmalate dehydrogenase enzyme essential
for the synthesis of leucine, was identified. An intriguing question is, how does
overexpression of LEU2 alleviate the growth defect of crd1Δ when the control
plasmid (YEp351), which contains the LEU2 marker, does not? The plasmid
used in this study contains a 2-micron origin of replication, which maintains 50100 copies of the plasmid per cell (Zakian et al., 1979). The LEU2 insert in
suppressors is expected to cause a two-fold increase in leucine content over the
control plasmid. This would suggest that supplementation of excess leucine in
the growth media may alleviate the growth defect of crd1Δ at elevated
temperature.
Interestingly, LEU2 was obtained as a suppressor that restored the growth
of YFH1 point mutants (yfh1-) in respiratory conditions (Bedekovics et al., 2011).
This study showed that leu2Δ abolished respiratory growth of yfh1, whereas
overexpression of LEU2 restored growth of the mutant by activating expression
of ACO1 (Bedekovics et al., 2011). The data presented in chapters two and three
show that CL is required for mitochondrial Fe-S biogenesis and CL deficiency
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leads to decreased Yfh1 protein, which suggests that in addition to the Fe-S
defect, leu2Δ may exacerbate the phenotype of crd1Δ, causing the growth defect
at elevated temperature. Therefore, overexpression of LEU2 may restore
decreased activity of Aco1 by increasing ACO1 transcription. To determine if
expression of ACO1 and the activity of the enzyme in crd1Δ are restored to WT
levels, LEU2 should be overexpressed in a plasmid containing a different
nutritional marker (e.g. URA3, TRP1, or HIS3). In addition to elucidating the role
of LEU2 in crd1Δ, the 45 suppressor plasmids should be sequenced to identify
the genes present.
In summary, the findings presented in chapters two and three show for the
first time that CL is required for maintaining Fe-S biogenesis and GSH
homeostasis. However the mechanism linking CL to these two processes is not
known. I invite my hard-working colleagues in the lab to identify the mechanism
based on the questions proposed here.
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Cardiolipin

(CL)

is

the

signature

phospholipid

of

mitochondrial

membranes, where it is synthesized locally and plays a critical role in
mitochondrial bioenergetic functions. Inside the mitochondria, CL is a critical
target of mitochondrial generated reactive oxygen species (ROS) and regulates
signaling events related to apoptosis and aging. CL deficiency causes
perturbation of signaling pathways outside the mitochondria, including the PKCSlt2 cell integrity pathway and the high osmolarity glycerol (HOG) pathway, and
is a key player in the cross-talk between the mitochondria and the vacuole. The
importance of CL in human health is underscored by the observation that
perturbation of CL biosynthesis causes the severe genetic disorder Barth
syndrome.
In order to fully understand the cellular response to the loss of CL,
genome-wide expression profiling was carried out in the yeast CL mutant crd1Δ.
The results show that the loss of CL in this mutant leads to increased expression
of iron uptake genes accompanied by elevated levels of mitochondrial iron and
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increased sensitivity to iron and hydrogen peroxide. Previous studies have
shown that increased mitochondrial iron levels result from perturbations in ironsulfur (Fe-S) cluster biogenesis. Consistent with an Fe-S defect, deletion of ISU1,
one of two ISU genes that encode the mitochondrial Fe-S scaffolding protein
essential for the synthesis of Fe-S clusters, led to synthetic growth defects with
the crd1Δ mutant. The crd1Δ mutant exhibits decreased activities of
mitochondrial Fe-S enzymes (aconitase, succinate dehydrogenase, and
ubiquinol-cytochrome c oxidoreductase), as well as cytosolic Fe-S enzymes
(sulfite reductase and isopropylmalate isomerase). Increased expression of
ATM1 or YAP1, which encode proteins involved in the export of mitochondrial
generated Fe-S co-factors to the cytosol and a transcription factor that regulates
several antioxidant genes, respectively, did not rescue the Fe-S defects in crd1Δ.
These findings show for the first time that CL is required for Fe-S biogenesis to
maintain mitochondrial and cellular iron homeostasis.
Consistent with the role of CL in mitochondrial Fe-S biogenesis,
perturbation of CL synthesis leads to decreased Yfh1 protein, a putative iron
donor for mitochondrial Fe-S cluster assembly, and reduced activities of Fe-S
enzymes aconitase and sulfite reductase, which are required for the synthesis of
glutamate and sulfur-containing amino acids (methionine and cysteine). The data
presented in this study show that the synthesis of glutamate and cysteine are
decreased in crd1Δ. Interestingly, both amino acids are required for the synthesis
of an essential antioxidant, glutathione (GSH), a tripeptide of glutamate, cysteine,
and glycine. The growth defect of crd1Δ at elevated temperature and in the
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presence of oxidants is rescued by GSH supplementation, which is consistent
with decreased synthesis of GSH. Collectively, these findings indicate that GSH
deficiency in crd1Δ is due to the depletion of precursors for GSH synthesis,
which is caused by defective Fe-S biogenesis.
To obtain an understanding of CL functions that might explain the cellular
defects in BTHS, a screen was carried out to identify genes that, when
overexpressed, suppress the growth deficiency of crd1Δ in galactose-containing
media at elevated temperature. The suppressor screen utilizing a high copy
genomic DNA library led to the identification of fifty putative suppressors of
crd1Δ. Five plasmids were intially sequenced, and interestingly, each plasmid
contained the same region of chromosome III, spanning four genes. One of the
genes was LEU2, which is involved in leucine biosynthesis, a process that is
perturbed in the crd1Δ mutant. This supports the finding that perturbation of
leucine synthesis likely contributes to the growth defect of crd1Δ.
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